<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Nutr Rep</journal-id><journal-id journal-id-type="iso-abbrev">Curr Nutr Rep</journal-id><journal-title-group><journal-title>Current Nutrition Reports</journal-title></journal-title-group><issn pub-type="epub">2161-3311</issn><publisher><publisher-name>Springer US</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39890748</article-id><article-id pub-id-type="pmc">PMC11785678</article-id><article-id pub-id-type="publisher-id">616</article-id><article-id pub-id-type="doi">10.1007/s13668-025-00616-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Longitudinal Effects of Lifetime Caffeine Consumption on Levels of Depression, Anxiety, and Stress: A Comprehensive Review</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0009-8400-5354</contrib-id><name><surname>Unsal</surname><given-names>Sena</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5937-0485</contrib-id><name><surname>Sanlier</surname><given-names>Nevin</given-names></name><address><email>nevintekgul@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01c9cnw16</institution-id><institution-id institution-id-type="ISNI">0000 0004 8398 8316</institution-id><institution>Department of Nutrition and Dietetics, Institute of Health Sciences, </institution><institution>Ankara Medipol University, </institution></institution-wrap>Alt&#x00131;nda&#x0011f;, Ankara, 06050 Turkey </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01c9cnw16</institution-id><institution-id institution-id-type="ISNI">0000 0004 8398 8316</institution-id><institution>Department of Nutrition and Dietetics, School of Health Sciences, </institution><institution>Ankara Medipol University, </institution></institution-wrap>Alt&#x00131;nda&#x0011f;, Ankara, 06050 Turkey </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>14</volume><issue>1</issue><elocation-id>26</elocation-id><history><date date-type="accepted"><day>16</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Purpose of Review</title><p id="Par1">Caffeine has high bioavailability and a purine-like alkaloid structure. It exerts wide-ranging physiological effects by binding to adenosine receptors throughout the human body. Through the activation of those receptors, it can regulate many physiological events in the body. The impact of caffeine consumption on depression, anxiety, stress, and human health remains unclear, constituting an important knowledge gap. This review was conducted to examine the effects of caffeine consumption on depression, anxiety, and stress levels and to offer some recommendations for its future use.</p></sec><sec><title>Recent Findings</title><p id="Par2">We performed a comprehensive literature search using PubMed, Web of Science and Google Scholar databases for original articles published in recent years on &#x0201c;caffeine metabolism&#x0201d;, &#x0201c;caffeine mechanism&#x0201d;, &#x0201c;anxiety&#x0201d;, &#x0201c;depression&#x0201d;, &#x0201c;stress&#x0201d;. Caffeine, which has an antagonistic effect on adenosine, can reduce the risk and symptoms of depression and improve general mental health by modulating the central nervous system and neurotransmitter systems. However, increases in anxiety and stress levels, which are often seen together with depression, are observed due to high-dose caffeine consumption.</p></sec><sec><title>Summary</title><p id="Par3">Caffeine&#x02019;s effects on depression, anxiety, and stress may vary depending on different factors, but the level of consumption is particularly important and attention should be paid to upper limits and reference values while evaluating consumption amounts.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Caffeine Metabolism</kwd><kwd>Depression</kwd><kwd>Anxiety</kwd><kwd>Stress</kwd></kwd-group><funding-group><award-group><funding-source><institution>Ankara Medipol University</institution></funding-source></award-group><open-access><p>Open access funding provided by the Scientific and Technological Research Council of T&#x000fc;rkiye (T&#x000dc;B&#x00130;TAK).</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media, LLC, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par4">Depression is a serious mood disorder that is common worldwide and reported at all sociodemographic levels. Approximately 280&#x000a0;million people in the world are affected by depression, also referred to as depressive disorder [<xref ref-type="bibr" rid="CR1">1</xref>]. Depression is characterized by the individual&#x02019;s loss of interest and pleasure and impaired emotional regulation, and it contributes to the global burden of disease by negatively affecting overall quality of life and body functions, with behaviors reflecting a depressive mood [<xref ref-type="bibr" rid="CR2">2</xref>]. Approximately 3.8% of the general population experiences depression, including 5% of adults and 5.7% of adults aged&#x02009;&#x0003e;&#x02009;60 years [<xref ref-type="bibr" rid="CR3">3</xref>]. Depression is approximately twice as likely to be seen in women as it is in men. Furthermore, more than 10% of pregnant and postpartum women worldwide experience depression [<xref ref-type="bibr" rid="CR4">4</xref>]. Despite the high prevalence of this disorder and the existence of proven treatment methods, fewer than 25% of individuals experiencing depression in low- and middle-income countries receive treatment [<xref ref-type="bibr" rid="CR5">5</xref>]. With a lifetime prevalence ranging between 1.5% and 19%, depression causes serious social problems with expensive treatments and high mortality and morbidity rates when not properly addressed [<xref ref-type="bibr" rid="CR6">6</xref>]. One example of this is suicide, which is particularly a major cause of death in the age group of 15&#x02013;29 years and may be associated with various mental disorders [<xref ref-type="bibr" rid="CR7">7</xref>]. Another common mental disorder observed worldwide is anxiety [<xref ref-type="bibr" rid="CR8">8</xref>]. Anxiety is a clinical situation associated with intense stress and characterized by excessive and unrealistic worries, and its severity increases as neurotransmitter synthesis decreases under conditions of chronic stress [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par5">Depression, anxiety, and stress occur together in many cases and can be described as risk factors for each other [<xref ref-type="bibr" rid="CR11">11</xref>]. In the etiology of these three interrelated conditions that affect mental health, environmental factors are especially important. In this context, nutrition is one of the most significant environmental etiological factors. Malnutrition may have a negative effect on the production and regulation of different neurotransmitters that play roles in the regulation of mental health and cognitive functions. While a variety of nutritional deficiencies can lead to depressive disorder, correcting those deficiencies plays a crucial role in preventing depressive disorder [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. In addition, with the growing recognition that lifestyle choices have a significant impact on mental health, the interaction between nutrition and mental health is becoming increasingly important as well [<xref ref-type="bibr" rid="CR13">13</xref>]. It is now thought that physical activity, particularly with nutritional models based on dietary diversity, may have positive effects on mental health and that malnutrition plays a role in the pathogenesis of psychological disorders [<xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par6">Although the pathogeneses of disorders such as depression, anxiety, and stress are not yet fully clear, the relationship between the consumption of caffeine from various sources and the risk of depression has received attention [<xref ref-type="bibr" rid="CR15">15</xref>]. Caffeine is absorbed rapidly and enters the circulation soon after dietary intake, and it acts on the central and peripheral nervous systems via adenosine receptors. While adenosine acts as an inhibitor of the release of neurotransmitters, caffeine has an antagonistic effect on adenosine and it prevents decreases in the release of neurotransmitters while also affecting dopamine activity in the mesolimbic dopamine pathway. Signal transmission in monoaminergic systems modulated in this way is thought to underlie caffeine&#x02019;s effects on behavior, perception, and thought processes, including various psychotic symptoms [<xref ref-type="bibr" rid="CR16">16</xref>]. Since caffeine, which is highly popular and can be consumed in various forms, has an extensive range of effects on the human body, its mechanisms of action, dosages of use, and side effects must be carefully evaluated [<xref ref-type="bibr" rid="CR17">17</xref>]. This review was conducted to examine the effects of caffeine consumption on depression, anxiety, and stress levels and to offer some recommendations for its future use.</p></sec><sec id="Sec2"><title>Method</title><p id="Par7">Using the PubMed, Web of Science, and Google Scholar databases, we conducted a comprehensive literature search of original articles published in recent years regarding &#x0201c;caffeine metabolism&#x0201d;, &#x0201c;caffeine mechanism&#x0201d;, &#x0201c;anxiety&#x0201d;, &#x0201c;depression&#x0201d; and &#x0201c;stress&#x0201d; published in recent years. No additional restrictions were imposed other than the selected search terms chosen. First, all search results were scanned by examining the titles and abstracts. Articles written in languages other than English or published as preprint versions were excluded during the screening process. In addition, articles that were not or only slightly related to our areas of interest as indicated by the titles and subtitles were excluded from the scope of the review.</p><sec id="Sec3"><title>Physical and Chemical Structure of Caffeine</title><p id="Par8">In addition to being found naturally in plants, caffeine was isolated in its pure form in 1820 and artificially produced through theobromine methylation in 1861 [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Caffeine, as one of the most heavily consumed psychoactive substances today, is a part of popular nutritional culture and is consumed in many forms, including energy drinks and nutritional supplements or ergogenic aids [<xref ref-type="bibr" rid="CR20">20</xref>]. Coffee, the most consumed source of caffeine, is a plant belonging to the genus <italic>Coffea</italic> of the family Rubiaceae, found mostly in North and Central Africa and in some regions of South and Central America and South Africa. More than seven million tons of raw coffee is produced annually worldwide. The seeds from the fruits of these trees are first roasted, ground, and turned into powder. The powder is then mixed with milk or water and a beverage is obtained [<xref ref-type="bibr" rid="CR21">21</xref>, 22].</p><p id="Par9">The chemical name for caffeine is 1,3,7-trimethylxanthine (C<sub>8</sub>H<sub>10</sub>N<sub>4</sub>O) and it is a psychoactive substance found naturally in plants [<xref ref-type="bibr" rid="CR21">21</xref>]. As a chemical, caffeine is white in color, odorless, bitter, and weakly basic, with a purine-like alkaloid crystal structure. It is soluble in water and organic solvents. Its chemical name, 1,3,7-trimethylxanthine, signifies that it is a compound formed by the bonding of a methyl group (CH<sub>3</sub>) to the first, third, and seventh carbons in its chemical structure. Caffeine has three metabolites: theophylline, theobromine, and paraxanthine. It can be obtained in pure form by adding CH<sub>3</sub> to theophylline and theobromine metabolites [<xref ref-type="bibr" rid="CR19">19</xref>]. As the main source of caffeine, coffee contains more than 1000 chemical compounds. Phenols such as chlorogenic and caffeic acid, lactones, diterpenes such as cafestol and kahweol, niacin and the niacin precursor trigonelline, magnesium, and potassium are some of these compounds. While 38&#x02013;42% of the dry weight of roasted coffee is carbohydrates, 23% is melanoids, 11&#x02013;17% is lipids, 10% is proteins, 4.5&#x02013;4.7% is minerals, 2.7&#x02013;3.1% is chlorogenic acid, 2.4&#x02013;2.5% is aliphatic acid, and 1.3&#x02013;2.4% is caffeine [<xref ref-type="bibr" rid="CR23">23</xref>]. The chemical structure of caffeine and some plants containing caffeine are given in Figs.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="Fig2" ref-type="fig">2</xref>.</p><p id="Par10">
<fig id="Fig1"><label>Fig. 1</label><caption><p>Chemical structure of caffein</p></caption><graphic xlink:href="13668_2025_616_Fig1_HTML" id="d33e297"/></fig>
</p><p id="Par11">
<fig id="Fig2"><label>Fig. 2</label><caption><p>Some plants source of caffeine</p></caption><graphic xlink:href="13668_2025_616_Fig2_HTML" id="d33e307"/></fig>
</p><p id="Par12">Another of the most widely consumed sources of caffeine is tea, obtained from the leaves and buds of <italic>Camellia sinensis</italic>, a plant belonging to the family Theaceae. Different types of tea are available according to different preparation methods, including black tea, green tea, white tea, and oolong. The chemical composition of tea includes polyphenolic compounds (catechins and epicatechins), theaflavins, flavonol glycosides, L-theanine, caffeine, theobromine, and volatile organic substances [<xref ref-type="bibr" rid="CR24">24</xref>]. However, the exact chemical composition and the amount of caffeine tea contains vary depending on the origin of the plant, the region where it was grown, and the processing method. Caffeine levels range between 1.5% and 5% among different types of tea, amounting to 30&#x000a0;mg of caffeine in a cup of green tea or about 50&#x000a0;mg in a cup of black tea [<xref ref-type="bibr" rid="CR25">25</xref>].</p></sec><sec id="Sec4"><title>Caffeine Sources and Consumption</title><p id="Par13">Caffeine is consumed by approximately 80% of the world&#x02019;s population today [<xref ref-type="bibr" rid="CR26">26</xref>]. In addition to differences in amounts of caffeine consumption, differences can also be observed in the sources of caffeine consumed around the world [<xref ref-type="bibr" rid="CR27">27</xref>]. Caffeine is found naturally in more than 60 plants, and the caffeine concentrations contained in its various sources depend on the type of plant, the region in which the plant was grown, and the production process [<xref ref-type="bibr" rid="CR26">26</xref>]. Caffeine can be found naturally in different amounts in the seeds, leaves, and fruits of many different plants including tea, coffee, kola nuts, cocoa beans, yerba mate, and guarana fruit; it is also present in cola, carbonated drinks, energy drinks, supplements, and some medications [<xref ref-type="bibr" rid="CR21">21</xref>, 22].</p></sec><sec id="Sec5"><title>Caffeine Absorption, Distribution, and Metabolism</title><p id="Par14">Caffeine is a substance with high bioavailability since it has no first-pass effect. However, caffeine metabolism may vary depending on different individual factors such as smoking or alcohol consumption, use of oral contraceptives, pregnancy, menopause, diet, age, and genetics [<xref ref-type="bibr" rid="CR28">28</xref>]. Depending on the dose taken, the half-life of caffeine is between 2.5 and 10&#x000a0;h. After consumption, caffeine is absorbed in the gastrointestinal tract within 30&#x02013;45&#x000a0;min, reaching the highest concentrations in plasma and being absorbed in the stomach and small intestine. Its levels rise rapidly in plasma and it is transported through the hepatic vein and spread evenly to all tissues of the body, including the brain. Due to its lipophilic properties, caffeine can pass through biological membranes and the blood-brain barrier with ease [<xref ref-type="bibr" rid="CR29">29</xref>]. It is metabolized by CYP1A2, the cytochrome P450 isoform found in liver cells, which breaks it down into theobromine (3,7-dimethylxanthine), paraxanthine (1,7-dimethylxanthine), and theophylline (1,3-dimethylxanthine) metabolites [<xref ref-type="bibr" rid="CR30">30</xref>]. Caffeine is primarily eliminated from the body through renal elimination; while approximately 0.5-2% is excreted in urine without being metabolized, 98% is reabsorbed from the renal tubules after glomerular filtration [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>].</p></sec><sec id="Sec6"><title>Caffeine&#x02019;s Functional Properties and Mechanisms of Action</title><p id="Par15">The physiological effects of caffeine on the body are based on a variety of mechanisms, which can be categorized into three main groups: calcium mobilization, phosphodiesterase inhibition, and adenosine receptor antagonism [<xref ref-type="bibr" rid="CR29">29</xref>]. Caffeine increases the release of intracellular Ca<sup>++</sup> by the sarcoplasmic reticulum and modulates Ca<sup>++</sup> channels, thus improving muscle excitation-contraction times and possibly exerting positive effects during endurance exercises [<xref ref-type="bibr" rid="CR33">33</xref>]. Additionally, caffeine binds to and activates ryanodine receptors, which have an important role in the neurotransmitter system, and affects synaptic transmission, which is dependent on Ca<sup>++</sup> release [<xref ref-type="bibr" rid="CR34">34</xref>]. According to the phosphodiesterase inhibition hypothesis, an increase in cyclic adenosine monophosphate (cAMP) concentrations within cells is observed as a result of caffeine&#x02019;s inhibition of the phosphodiesterase enzyme found in skeletal muscle and adipose tissues. With increasing cAMP, the activation of glycerol, free fatty acids, and lipases also increases and lipolysis is stimulated [<xref ref-type="bibr" rid="CR34">34</xref>]. Muscle glycogen preservation and muscle functional capacity increase as a result. However, doses much higher than therapeutic doses are needed to produce the effects described here for both calcium mobilization and phosphodiesterase inhibition mechanisms, and it is thought that there is no active mechanism in the case of behavioral effects [<xref ref-type="bibr" rid="CR35">35</xref>].</p><p id="Par16">The primary effective mechanism of caffeine is considered to be adenosine antagonism [<xref ref-type="bibr" rid="CR36">36</xref>]. In particular, the effects of non-toxic caffeine concentrations on synaptic transmission and plasticity in the mouse hippocampus are based on adenosine receptor antagonism. Moreover, adenosine A1 receptors appear to be responsible for the effects of caffeine on synaptic transmission, while adenosine A2A receptors regulate the long-term potentiation effects of caffeine [<xref ref-type="bibr" rid="CR37">37</xref>]. Adenosine is an endogenous nucleoside formed by the combination of a ribose pentose ring and an adenine purine base, and it has inhibitory effects on both the peripheral and central nervous systems [<xref ref-type="bibr" rid="CR38">38</xref>]. Being structurally similar to adenosine, caffeine competes with adenosine to bind to adenosine receptors and exerts a stimulating effect as an adenosine antagonist. In binding to adenosine, it prevents decreases in the concentrations of neurotransmitter molecules and provides mental and physical benefits by acting on the dopaminergic, glutamatergic, serotonergic, cholinergic, GABAergic (gamma-amino-butyric), and noradrenergic systems [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. In addition, since quilibrative nucleoside transporter-2 (ENT2) mediated adenosine signalling in V1 is the neurochemical basis of 40&#x000a0;Hz vibration-induced sleep (non-REM and REM sleep), a novel non-invasive treatment is also thought to be useful [<xref ref-type="bibr" rid="CR40">40</xref>]. Adenosine-A2A receptor signalling has emerged as the neurochemical basis of 40&#x000a0;Hz vibration-induced glymphatic flow through increased cerebrofluid adenosine levels, elimination of increased glymphatic flow by pharmacological or genetic inactivation of compensatory nucleotide transporters-2 or A2AR, and physical and functional A2A receptor-aquaporin-4 interaction in astrocytes. It would provide the potential therapeutic advantage of allosteric modulators of adenosine A2A receptors over classical agonists and antagonists for treating sleep and neurological disorders [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. The primary functional feature driving the frequent consumption of caffeine is its ability to increase alertness and concentration by affecting the central nervous system [<xref ref-type="bibr" rid="CR43">43</xref>]. However, it has been suggested that high caffeine intake may negatively affect academic success by causing behavioral and psychosocial problems [<xref ref-type="bibr" rid="CR44">44</xref>].</p><p id="Par17">Another functional feature of caffeine is its ability to exert an anti-inflammatory effect by reducing the levels of proinflammatory molecules. In individuals receiving caffeine supplementation at varying doses, significant reductions in concentrations of cytokines including interleukin (IL)-8, IL-10, IL-6, IL-2, IL-4, interferon gamma (IFN-&#x003b3;), granulocyte-macrophage colony-stimulating factor (GM-CSF), macrophage inflammatory protein 1&#x003b2; (MIP-1&#x003b2;), monocyte chemoattractant protein-1 (MCP-1), and tumor necrosis factor (TNF) have been reported, even at the lowest dose [<xref ref-type="bibr" rid="CR45">45</xref>]. It is thought that 3&#x02013;5&#x000a0;mg/kg caffeine consumption may be effective in preventing the development of neurodegenerative diseases such as Alzheimer&#x02019;s and Parkinson&#x02019;s thanks to its neuroprotective effects [<xref ref-type="bibr" rid="CR46">46</xref>]. Additionally, caffeine imparts various benefits such as alertness and antidiabetic, anti-obesity, and anticancer activities with increased concentrations [<xref ref-type="bibr" rid="CR47">47</xref>]. The effects of caffeine absorption, distribution, metabolism, and consumption on depression, anxiety, and stress levels are illustrated in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>. The caffeine contents of various beverages, foods and districts are presented in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.</p><p id="Par18">
<fig id="Fig3"><label>Fig. 3</label><caption><p>The effects of caffeine absorption, distribution, metabolism, and consumption on depression, anxiety, and stress levels</p></caption><graphic xlink:href="13668_2025_616_Fig3_HTML" id="d33e439"/></fig>
</p></sec><sec id="Sec7"><title>Effects of Caffeine Consumption on Depression, Anxiety, and Stress Levels</title><p id="Par19">Depression, anxiety, and stress are common mood disorders that have strong relationships with each other [<xref ref-type="bibr" rid="CR11">11</xref>].</p></sec><sec id="Sec8"><title>Depression</title><p id="Par20">Depression differs clearly from normal mood changes and emotions related to daily life and it seriously affects the global population today [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. Depression is defined as a serious mood disorder that causes a permanent feeling of sadness, loss of interest and pleasure, and reduced quality of life [<xref ref-type="bibr" rid="CR50">50</xref>]. Although the etiology of depression has not yet been satisfactorily explained, it is thought that it may develop due to biological factors, chronic diseases, economic situations, stress, grief, abuse or trauma history, drug and substance use, alcohol consumption, and/or genetic factors [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. In the diagnosis of depression, at least 5 of the criteria specified in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) must be observed for a minimum of 2 weeks [<xref ref-type="bibr" rid="CR9">9</xref>]. There are different theories on the pathogenesis of depression, including disorders of monoaminergic systems, neuroplasticity, increased inflammation, dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, genetics, and environmental factors. However, the most common treatment approaches address disorders of monoaminergic systems. There are many serotonergic, dopaminergic, and noradrenergic neurons in many regions of the brain. Accordingly, monoaminergic systems are responsible for many behavioral symptoms such as mood, alertness, motivation, fatigue, and psychomotor performance [<xref ref-type="bibr" rid="CR52">52</xref>]. According to the hypothesis of disorders of monoaminergic systems, depression develops due to decreases in the concentrations of serotonin, norepinephrine, and dopamine monoamine neurotransmitters or abnormalities in their receptors [<xref ref-type="bibr" rid="CR53">53</xref>].</p><p id="Par21">Caffeine&#x02019;s effect on depressive symptoms is generally associated with disorders of monoaminergic systems, whereby its mechanism of action is based on adenosine receptor antagonism [<xref ref-type="bibr" rid="CR54">54</xref>]. The functions of adenosine receptors are distinct. Activation of A2A receptors is associated with increased depressive symptoms, while increased A1 receptor signalling produces antidepressant effects. A2A receptor increase is associated with a decrease in synaptic plasticity and density of synaptic proteins. Furthermore, A2A receptors may cause inhibition of A1 receptors [<xref ref-type="bibr" rid="CR55">55</xref>]. It is thought that maximum neuroprotection can be achieved with a combination of A2A receptor blockade and increased A1 receptor activation [<xref ref-type="bibr" rid="CR56">56</xref>].</p><p id="Par22">As explained in more detail in Sect.&#x000a0;5 on the mechanisms of action of caffeine [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>], caffeine and adenosine are structurally similar but have antagonistic effects. Adenosine acts as a neurotransmitter inhibitor, while caffeine, which competes with it, exerts the opposite effect, increasing the release of neurotransmitters [<xref ref-type="bibr" rid="CR54">54</xref>]. On the other hand, decreases in the concentrations of neurotransmitters are observed in cases of depression. Thus, caffeine, which binds to adenosine receptors in various parts of the brain such as the striatum, hippocampus, amygdala, and prefrontal campus, can affect both behavioral and cognitive health in a wide range of areas through the modulation of neurotransmitter systems that are impaired in depression [<xref ref-type="bibr" rid="CR57">57</xref>]. A significant inverse relationship was reported between caffeine intake and depression scores, and the possible mechanism was attributed to adenosine antagonism [<xref ref-type="bibr" rid="CR58">58</xref>]. Considering dopamine concentrations, which may particularly decrease in cases of depression, the fact that A2A receptors are expressed in dopamine-rich areas with dopamine receptors and A2A receptors sharing a signaling pathway suggests that caffeine may help in alleviating depression by exerting a dopaminergic effect [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. Consequently, by increasing the release of neurotransmitters (i.e., dopamine, norepinephrine, and serotonin) with that dopaminergic effect, caffeine stimulates psychomotor activities, increases concentration, and can improve general mood and cognitive functions [<xref ref-type="bibr" rid="CR59">59</xref>]. According to the European Food Safety Authority (EFSA), in order for such cognitive and psychological effects to occur, caffeine consumption of approximately 75&#x000a0;mg is required, ignoring individual differences [<xref ref-type="bibr" rid="CR60">60</xref>]. In addition to dopamine, caffeine is also associated with glutamine and GABA. It was reported that the increase in A2A receptors in mice prone to depression caused a decrease in glutamine and GABAergic markers and that those effects disappeared following the administration of caffeine [<xref ref-type="bibr" rid="CR61">61</xref>]. Another study concluded that caffeine intake increased the sensitivity of dopamine receptors by two- to threefold [<xref ref-type="bibr" rid="CR62">62</xref>].</p><p id="Par23">Impairment of hippocampal neurogenesis is one of the etiological factors of depression and can be affected by various factors such as stress. Especially in mice exposed to chronic stress, decreased neurogenesis and neuroinflammation were observed [<xref ref-type="bibr" rid="CR63">63</xref>]. In a study, it was reported that caffeine prevented the decrease in neurogenesis by suppressing corticosterone-induced microglia activation. In addition, the antidepressant effect of caffeine was highlighted in the study [<xref ref-type="bibr" rid="CR64">64</xref>]. By other hypothesized mechanisms of action, caffeine is thought to affect inflammation and neuroplasticity. In the context of depression, caffeine interacts with A1 and A2A receptors, increases basal transmission, and improves depressive symptoms by preventing the decrease of brain-derived neurotrophic factor (BDNF) [<xref ref-type="bibr" rid="CR65">65</xref>]. In a study conducted with mice, it was reported that caffeine consumption of 10&#x000a0;mg/kg/day for 2 weeks decreased neuroinflammatory markers, increased BDNF levels, and improved depressive symptoms [<xref ref-type="bibr" rid="CR66">66</xref>]. In a study conducted with middle-aged individuals, participants who consumed at least 4 cups of coffee per day had a lower risk of depression compared to participants who consumed&#x02009;&#x0003c;&#x02009;1 cup of coffee per day. Additionally, no significant relationship was found between decaffeinated coffee consumption and depression [<xref ref-type="bibr" rid="CR67">67</xref>]. In another study on black tea consumption, it was observed that daily consumption of up to 4 cups of black tea was protective against depression [<xref ref-type="bibr" rid="CR68">68</xref>]. In a study conducted in Korea, green tea, coffee, and caffeine consumption were inversely associated with the risk of depression. That risk was 21% higher in individuals who did not consume green tea compared to those who consumed it regularly (at least 3 cups a week), while individuals who did not drink coffee had a 32% higher risk of depression than individuals who consumed it regularly [<xref ref-type="bibr" rid="CR69">69</xref>]. In a human study conducted in Portugal, fMRI results were examined in individuals with habitual coffee consumption. According to the results, after coffee intake, posterior default mode network (DMN) connectivity decreased, but connectivity in higher visual and right executive control network (RECN) nodes increased [<xref ref-type="bibr" rid="CR70">70</xref>]. Another study reported that habitual consumption of coffee and caffeinated products affects the functional connectivity of the human brain. In addition, although it was not associated with depression in the study, the stress level was found to be higher in regular coffee drinkers compared to non-coffee drinkers [<xref ref-type="bibr" rid="CR71">71</xref>].</p><p id="Par24">The prevalence of elderly depression is increasing as well as in the young adult population [<xref ref-type="bibr" rid="CR72">72</xref>]. Regular moderate coffee consumption reduces various causes of mortality such as cardiovascular diseases, cancer, depression and cognitive disorders. It is also promising for good mood and well-being in old age [<xref ref-type="bibr" rid="CR73">73</xref>]. In another study, it was reported that individuals with higher coffee consumption had younger biological ages compared to their chronological age [<xref ref-type="bibr" rid="CR74">74</xref>]. Therefore, caffeine and especially coffee consumption supports a healthy ageing.</p><p id="Par25">When depression is not treated, serious morbidity and mortality rates are observed. One of the major causes of death in depression is suicide [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. According to the results of three large American cohort studies, coffee consumption was associated with a lower risk of suicide, while decaffeinated coffee was not associated with a lower risk of suicide. This situation draws attention to the effect of caffeine rather than other components of coffee [<xref ref-type="bibr" rid="CR75">75</xref>]. On the other hand, a study conducted in Korea reported that excessive consumption of energy drinks was associated with depression and suicidal ideation [<xref ref-type="bibr" rid="CR76">76</xref>].</p><p id="Par26">Studies have reported varying results regarding the effects of different caffeine sources. In a meta-analysis study, it was emphasized that increase in coffee intake of 240 mL reduced the risk of depression by 4%, while there was no significant relationship between tea consumption and depression. The only significant relationship reported was that among caffeine, coffee, and depression [<xref ref-type="bibr" rid="CR77">77</xref>]. In a meta-analysis of observational studies, coffee consumption was found to reduce the risk of depression by 8%, but it was stated that more studies on caffeine are needed [<xref ref-type="bibr" rid="CR15">15</xref>]. Although one study associated increased caffeine metabolites in urine with a non-significant increase in depression risk [<xref ref-type="bibr" rid="CR78">78</xref>], a study on mice reported that caffeine had an antidepressant-like effect [<xref ref-type="bibr" rid="CR79">79</xref>].</p><p id="Par27">Recently, the relationship between genes in adenosine receptors and mood disorders has attracted attention. In a study, it was reported that single nucleotide polymorphism in adenosine A2A receptor genes (ADORA2A) was associated with depression in terms of clinical heterogeneity. Especially in individuals with TT genotype, depression was associated with a lower risk of sleep disturbance and attention disorder [<xref ref-type="bibr" rid="CR80">80</xref>]. In a study conducted in Finland, it was reported that compromised adenosine transport due to SLC29A3 polymorphism may predispose women to depression [<xref ref-type="bibr" rid="CR81">81</xref>].</p><p id="Par28">Contradictions are also observed in studies exploring the relationship between dose and depressive symptoms. In a comprehensive study, it was found that moderate daily caffeine intake (119.52&#x02013;236.5&#x000a0;mg) reduced the risk of depression; in particular, individuals consuming an average of 119.52&#x000a0;mg of caffeine constituted the lowest risk group [<xref ref-type="bibr" rid="CR82">82</xref>]. In a study on the efficacy of low-dose caffeine, a significant relationship was found only between &#x0003c;&#x02009;90&#x000a0;mg caffeine intake and depressive symptoms. According to that study, no significant relationship existed between &#x0003e;&#x02009;90&#x000a0;mg caffeine intake and depression scores [<xref ref-type="bibr" rid="CR65">65</xref>]. On the other hand, a study conducted with a Japanese population showed a significant relationship with depression for caffeine intake up to a maximum of 291&#x000a0;mg/day [<xref ref-type="bibr" rid="CR83">83</xref>]. In a systematic review, it was reported that the use of caffeine to reduce the negative effects of depression, anxiety, stress, and sleep patterns for academic success and ongoing clinical education has increased significantly in recent years and that moderate doses of caffeine provide benefits, but side effects are also observed at high doses [<xref ref-type="bibr" rid="CR84">84</xref>]. While low (~&#x02009;50&#x02013;250&#x000a0;mg) and moderate (~&#x02009;250&#x02013;400&#x000a0;mg) caffeine intake is thought to improve physical-cognitive performance, general mood, and depressive symptoms, it is reported that higher levels of caffeine intake have an anxiogenic-like effect and may have negative effects on depression [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR85">85</xref>]. Correlations regarding caffeine intake amounts, as well as timing and the optimal effects of caffeine intake, remain uncertain. The circadian rhythm may play a role in the psychological and cognitive effects of caffeine. Caffeine can change the circadian rhythm by affecting the gene expression of suprachiasmatic nuclei, which are located in the hypothalamus and control the circadian rhythm [<xref ref-type="bibr" rid="CR86">86</xref>]. One study showed that caffeine intake in the evening may change the circadian rhythm by delaying the secretion of melatonin, thus reducing sleep quality [<xref ref-type="bibr" rid="CR87">87</xref>]. In a study examining the relationship between caffeine intake timing and depression in the American adult population, it was found that the incidence of depression was lower among individuals who consumed caffeine in the early morning hours (05:00&#x02013;08:00) compared to individuals who did not consume it early in the day [<xref ref-type="bibr" rid="CR88">88</xref>].</p></sec><sec id="Sec9"><title>Anxiety</title><p id="Par29">Anxiety is a mood disorder that can be accompanied by physiological somatic symptoms, with feelings of worry and fear occurring at different intensities. It is reported that 68% of individuals experiencing anxiety disorders have another accompanying psychiatric disease [<xref ref-type="bibr" rid="CR89">89</xref>]. According to the DSM-V, anxiety disorders encompass multiple subtypes, such as generalized anxiety disorder, agoraphobia, obsessive-compulsive disorder, and panic attack disorder [<xref ref-type="bibr" rid="CR9">9</xref>]. Anxiety disorders, similarly to other mental health problems, are the result of complex interactions of social, psychological, and biological factors. Stressful living conditions, trauma, family history of mood disorders, drug use, and the presence of concomitant psychological disorders such as depression are considered to be risk factors [<xref ref-type="bibr" rid="CR90">90</xref>]. Today, approximately 4% of the global population suffers from an anxiety disorder. According to data from 2019, 301&#x000a0;million individuals in the world, or about 3.8% of the global human population, have anxiety disorders, making them the most common of all mental disorders [<xref ref-type="bibr" rid="CR3">3</xref>]. The mechanism of caffeine&#x02019;s anxiogenic effect is not yet clearly known. However, due to its adenosine receptor antagonism, caffeine can cause symptoms such as hyperventilation and shortness of breath, which are characterized by anxiety, suggesting that caffeine may have common mechanisms for respiratory distress [<xref ref-type="bibr" rid="CR91">91</xref>]. A2A receptors, in particular, are more associated with anxiety behaviour [<xref ref-type="bibr" rid="CR55">55</xref>]. On the other hand, it is thought that the serotonergic system is involved in the development and maintenance of anxiety disorders and that caffeine changes serotonergic neuron activity and serotonergic gene expression [<xref ref-type="bibr" rid="CR92">92</xref>].</p><p id="Par30">In the relationship between caffeine dose and anxiety, it is generally reported that low to moderate levels (40&#x02013;300&#x000a0;mg) of caffeine have positive effects on mood, while high levels (&#x0003e;&#x02009;400&#x000a0;mg) of caffeine consumption may have anxiogenic effects [<xref ref-type="bibr" rid="CR93">93</xref>]. In addition, a study conducted with Australian young adults found that energy drinks with high caffeine contents (limited to 320&#x000a0;g/L) increased anxiety [<xref ref-type="bibr" rid="CR94">94</xref>]. Another study reported that the consumption of 2&#x02013;3 cups of coffee per day is associated with a lower risk of depression and anxiety, but intake of &#x0003e;&#x02009;6 cups of coffee may lead to an increase in anxiety [<xref ref-type="bibr" rid="CR95">95</xref>]. While a study conducted in Iran reported that those who consumed&#x02009;&#x02265;&#x02009;1 cup of coffee per week had a significantly reduced likelihood of depression and anxiety symptoms, no significant relationship was found between the occurrence of symptoms and caffeine/coffee consumption [<xref ref-type="bibr" rid="CR96">96</xref>]. According to another study, among individuals whose average daily caffeine intake was 268&#x000a0;mg, symptoms such as headache, panic attack, and anxiety were observed, especially with high caffeine intake of &#x0003e;&#x02009;400 mg [<xref ref-type="bibr" rid="CR97">97</xref>].</p><p id="Par31">In addition to the daily dose, acute and chronic caffeine consumption should be evaluated. A rat study demonstrated that acute and chronic caffeine treatment in rats under acute or chronic stress reduced oxidative stress markers such as nitric oxide and lipid peroxidation and improved anxiety and cognitive functions [<xref ref-type="bibr" rid="CR98">98</xref>]. In another study, acute caffeine intervention affected behaviour and mRNA gene expression, but different results were found in behaviour and striatal A2A receptors expression in animals showing high or low anxiety-like behaviour [<xref ref-type="bibr" rid="CR99">99</xref>]. In a study in which long-term caffeine intervention was examined, A1R expression increased in the frontal cortex, while A2A receptors expression increased in the hippocampus and caudate putamen [<xref ref-type="bibr" rid="CR100">100</xref>]. In a rat study, acute caffeine administration (20 or 40&#x000a0;mg/kg) decreased aggression behaviours, but chronic caffeine administration (50 or 100&#x000a0;mg/kg) showed no change. This was explained because chronic caffeine administration caused the development of tolerance [<xref ref-type="bibr" rid="CR101">101</xref>]. It is thought that the contradictory results in acute and chronic caffeine administration may be due to the presence of other signalling pathways against tolerance or acute response [<xref ref-type="bibr" rid="CR99">99</xref>].</p><p id="Par32">Several factors play roles in the heterogeneity observed in the relationship between caffeine and anxiety. The first of these factors is the caffeine habit. When regular caffeine intake is ceased abruptly, individuals may experience caffeine withdrawal symptoms including increased anxiety and depression [<xref ref-type="bibr" rid="CR102">102</xref>]. The second important factor is genetics. It is thought that the single-nucleotide polymorphism seen in the CYPA12 gene affects the enzyme activity in caffeine metabolism, and it is hypothesized that variations in the ADORA2A gene stimulate dopaminergic transamination by affecting adenosine receptor-caffeine binding [<xref ref-type="bibr" rid="CR103">103</xref>, <xref ref-type="bibr" rid="CR104">104</xref>]. In a systematic review, it was reported that there is an interaction between anxiety and caffeine and that ADORA2A gene polymorphisms increase the sensitivity of caffeine to anxiogenic effects, thus creating individual patterns in caffeine metabolism [<xref ref-type="bibr" rid="CR104">104</xref>]. In the systematic review conducted by Fulton et al., individuals with the ADORA2A (rs5751876) TT genotype were found to have higher anxiety levels following caffeine intake and it was further suggested that, even if polymorphism is observed, tolerance to the anxiogenic effect may develop [<xref ref-type="bibr" rid="CR105">105</xref>]. More studies on this subject are needed for definitive evidence of gene interactions, caffeine addiction, and the relationship between dose and anxiety.</p></sec><sec id="Sec10"><title>Stress</title><p id="Par33">Stress is a state of anxiety or mental tension caused by difficult situations; it is a natural human response that allows us to manage challenges and threats in our lives. Everyone experiences stress to some extent, and certain levels of stress can be beneficial throughout our lives. However, high levels of stress can cause physical and mental health problems [<xref ref-type="bibr" rid="CR106">106</xref>]. The disruption of homeostasis in the body can be caused by many different individual and environmental factors, which are defined as stress factors. Hence, stress constitutes a physical or psychological negative condition that disrupts homeostasis, and stress response is described as the body&#x02019;s response to a negative situation to sustain homeostasis [<xref ref-type="bibr" rid="CR107">107</xref>]. Two neuroendocrine physiological systems, the sympathetic-adreno-medullary (SAM) axis and the hypothalamic-pituitary-adrenal (HPA) axis, play roles in maintaining homeostasis against stressors [<xref ref-type="bibr" rid="CR108">108</xref>]. In the rapid initial response, norepinephrine and epinephrine are increased via the SAM axis. Subsequently, in the slow response, the release of various glucocorticoid hormones increases with HPA axis activation and negative feedback is created [<xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]. As a result, physical symptoms such as increased heart rate, blood pressure, respiratory rate, lipolysis, gluconeogenesis, and changes in appetite are observed together with mental symptoms such as irritability, difficulty concentrating, and alertness [<xref ref-type="bibr" rid="CR109">109</xref>].</p><p id="Par34">Adenosine is thought to prevent the behavioral, neurochemical, and electrophysiological changes caused by stress by exerting an antagonistic effect on the A2A receptor, similar to the effects of caffeine on depression and anxiety [<xref ref-type="bibr" rid="CR110">110</xref>]. In mouse models of repeated stress-induced depression, an abnormal increase in A2A receptor signalling in the lateral septum (LS) was observed and implicated as an upstream regulator of stress-induced depressive-like behaviour. The antidepressant capacity of A2A receptor antagonists is based on this neurophysiological basis [<xref ref-type="bibr" rid="CR111">111</xref>]. On this basis, a study showed that regular-chronic caffeine consumption improved locomotor activity and reversed stress-induced depression and avoidance of social behaviour [<xref ref-type="bibr" rid="CR112">112</xref>]. An important point for stress-induced behavioural changes is well-being. In a study conducted with mice, it was reported that moderate doses of caffeinated coffee improved well-being and behaviour in both male and female mice, however, decaffeinated coffee did not cause behavioural improvement in both sexes [<xref ref-type="bibr" rid="CR113">113</xref>].</p><p id="Par35">One study found that most students consume low levels of caffeine on regular days but consume moderate levels during exam periods. It was reported that 8% of participating students consumed caffeine to cope with stress, while 35.7% consumed caffeine for a better mood and 3.57% to manage depression. The authors concluded that caffeine consumption can be considered a method of stress management and that it tends to increase during stressful periods [<xref ref-type="bibr" rid="CR114">114</xref>]. While one study showed that high levels of caffeine consumption increased stress levels [<xref ref-type="bibr" rid="CR115">115</xref>], in another study, no relationship was found between Depression, Anxiety and Stress Scale (DASS-21) scores and daily caffeine consumption [<xref ref-type="bibr" rid="CR116">116</xref>]. On the other hand, a study conducted in Turkey reported that high levels of caffeine consumption increased anxiety and stress scores and that female gender, smoking, economic status, geographical location, and increasing age were among the factors affecting consumption [<xref ref-type="bibr" rid="CR117">117</xref>].</p><p id="Par36">To summarize, although there are varying findings on the relationship between caffeine and stress, the main factor determining this effect is the dose, with higher levels of caffeine consumption increasing stress.</p></sec><sec id="Sec11"><title>Safe Dosages of Caffeine Intake</title><p id="Par37">The dose consumed is important in the effectiveness of caffeine consumption. Its effectiveness varies depending on the dose, and side effects and even toxicity may be observed at high doses. According to recommendations of the EFSA, the tolerable upper limit of caffeine intake is specified as 400&#x000a0;mg for adults, 3&#x000a0;mg/kg for children and adolescents, and 200&#x000a0;mg/g for pregnant women. In a single dose, the caffeine intake limit is 200&#x000a0;mg/day [<xref ref-type="bibr" rid="CR60">60</xref>]. Similarly, the U.S. Food and Drug Administration (FDA) states that there are no safety concerns at up to 400&#x000a0;mg, equivalent to about 4 cups of coffee [<xref ref-type="bibr" rid="CR118">118</xref>]2023). A maximum of 2.5&#x000a0;mg/kg of caffeine per day is the recommended safe intake dose for children and adolescents according to Health Canada recommendations [<xref ref-type="bibr" rid="CR119">119</xref>]. The average serum caffeine concentration was found to be 5.3&#x000a0;mg/L one hour after daily consumption of 2 cups of strong coffee [<xref ref-type="bibr" rid="CR120">120</xref>]. If serum caffeine concentrations are &#x0003e;&#x02009;15&#x000a0;mg/L after consuming about 6 cups of strong coffee, side effects such as insomnia, restlessness, nausea, headache, dizziness, spasm, edema, hypoglycemia, hypokalemia, increased blood pressure, and cardiac arrhythmias begin to occur, while fatal effects can be observed with serum concentrations of &#x0003e;&#x02009;80&#x000a0;mg/L [<xref ref-type="bibr" rid="CR121">121</xref>]. It has been found that daily consumption of &#x0003e;&#x02009;1&#x000a0;g of caffeine can cause toxic effects. Additionally, there is variation in the optimal consumption values presented in the literature and individual factors are believed to have an impact on this situation [<xref ref-type="bibr" rid="CR20">20</xref>].</p></sec><sec id="Sec12"><title>Side Effects of Caffeine</title><p id="Par38">While positive effects of low to moderate amounts of caffeine are observed, high amounts may cause negative effects. The main factor causing side effects due to caffeine intake is the dose consumed. Side effects increase in proportion to the consumed dose [<xref ref-type="bibr" rid="CR122">122</xref>, <xref ref-type="bibr" rid="CR123">123</xref>]. Some examples of side effects include tachycardia and heart palpitations, anxiety, tension, irritability, anxiety, headache, gastrointestinal problems, nausea, increase in blood pressure, insomnia, poor sleep quality, and diuresis, which leads to fluid and electrolyte loss and decrease in plasma [<xref ref-type="bibr" rid="CR123">123</xref>].</p></sec><sec id="Sec13"><title>Conclusion and Recommendations</title><p id="Par39">Caffeine is an adenosine antagonist that functions as an inhibitory neuromodulator. Therefore, it can increase cognitive and mental functions by affecting the central nervous system and neurotransmitter systems. Accordingly, it is thought that consuming moderate amounts of caffeine can prevent stress, anxiety, and depression, reducing depressive symptoms and improving general mental health. On the other hand, high doses of caffeine are thought to be associated with increased anxiety and stress. It is also known that its effects may vary depending on the type of coffee consumed and the brewing method in addition to the amount consumed. The caffeine in coffee affects the emotional state and cognitive functions of those who consume it by stimulating the central nervous system. This effect may be associated with depression and anxiety. Caffeine increases dopamine production by blocking adenosine receptors, which can lead to a more positive mood. However, the results of studies on the correlations between coffee consumption and depression, stress, and anxiety are still uncertain. More clinical and epidemiological studies are needed to clearly explain the mechanisms of caffeine&#x02019;s effects and the role of genetic factors in the impact of caffeine consumption on depression, stress, and anxiety. Evidence-based data to determine the optimal amount of consumption must be produced.</p></sec><sec id="Sec14"><title>Future Perspective</title><p id="Par40">Caffeine is most commonly found in coffee, as well as chocolate, tea, cola, energy drinks, and some medications. Studies report that coffee consumption is advantageous for the majority of people and may have positive associations with conditions such as cancer or cardiovascular, immunological, inflammatory, and neurological diseases. However, high levels of caffeine intake can have harmful effects on the growth and development of children and may cause cognitive impairment in the fetuses of pregnant women who consume it heavily. It may also have negative effects in patient groups with particular conditions and people who are sensitive to caffeine, increasing their susceptibility to diseases in adulthood. Caffeine intake should be restricted or reduced to avoid these negative effects. However, moderate caffeine intake can serve as a healthy way to help prevent various diseases. While the numbers of research studies and meta-analyses continue to grow, the scientific evidence in the current literature remains insufficient to confirm the quality and quantity of caffeine for optimal benefits. To clarify the link between caffeine consumption and specific diseases, reduce side effects, and increase bioavailability, epidemiological and randomized controlled trials are needed together with in vivo, in vitro, animal, and human studies to examine innovative applications of caffeine and consumption patterns in relation to health outcomes. In addition, since most studies conducted to date have focused on adults, little knowledge is available about the effects of consuming caffeinated products among children and adolescents. In the future, the absorption, metabolism, bioactivity, and health benefits of caffeine should be evaluated for different age groups and its mechanisms of action should be further examined.</p><p id="Par41">
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Various caffeine sources and their concentrations [<xref ref-type="bibr" rid="CR38">38</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Substance</th><th align="left">Serving Size<break/>(mL/ g/ tablet)</th><th align="left">Caffeine Content<break/>(mg)</th></tr></thead><tbody><tr><td align="left" colspan="3">
<bold>Beverages</bold>
</td></tr><tr><td align="left"><p>Turkish Coffee</p><p>Filter Coffee</p><p>Espresso</p><p>Americano</p><p>Instant Coffee</p><p>Decaffeinated</p><p>Black Tea</p><p>Green Tea</p><p>Chocolate Milk</p><p>Standard Can of Cola</p><p>Standard Energy Drink</p></td><td align="left"><p>85&#x02013;90</p><p>200</p><p>60</p><p>355</p><p>150</p><p>240</p><p>220</p><p>240</p><p>225</p><p>355</p><p>250</p></td><td align="left"><p>60</p><p>90</p><p>80</p><p>150</p><p>60</p><p>2</p><p>50</p><p>45</p><p>2&#x02013;7</p><p>40</p><p>80</p></td></tr><tr><td align="left">
<bold>Foods</bold>
</td><td align="left">(g)</td><td align="left"/></tr><tr><td align="left"><p>Plain Chocolate</p><p>Milk Chocolate</p><p>Dark Chocolate (%60&#x02013;85)</p><p>Dark Chocolate (%45&#x02013;59)</p><p>White Chocolate</p><p>Chocolate Pudding</p><p>Cocoa Powder</p><p>Chocolate Ice-cream</p></td><td align="left"><p>50</p><p>50</p><p>100</p><p>100</p><p>100</p><p>100</p><p>100</p><p>50</p><p>2 tablet</p><p>1 tablet</p><p>2&#x02013;3 tablet</p></td><td align="left"><p>25</p><p>10</p><p>82</p><p>43</p><p>0</p><p>2</p><p>120</p><p>2&#x02013;5</p><p>65&#x02013;130</p><p>200</p><p>80&#x02013;200</p></td></tr><tr><td align="left" colspan="3">
<bold>Drugs</bold>
</td></tr><tr><td align="left"><p>Painkiller</p><p>Some stimulant medications</p><p>Slimming drug</p></td><td align="left"><p>2 tablet</p><p>1 tablet</p><p>2&#x02013;3 tablet</p></td><td align="left"><p>65&#x02013;130</p><p>200</p><p>80&#x02013;200</p></td></tr></tbody></table></table-wrap>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author Contributions</title><p>N.S. created the design and draft of the study. All authors conducted the literature research and writing-reviewed and prepared the figures and tables. N.S. authored and critically revised the draft of the paper. All authors read and approved the version of the manuscript. All authors contributed to the study conception and design.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open access funding provided by the Scientific and Technological Research Council of T&#x000fc;rkiye (T&#x000dc;B&#x00130;TAK).</p></notes><notes notes-type="data-availability"><title>Data Availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar524"><title>Ethical Approval</title><p id="Par42">The papers cited involving the use of human subjects, have been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The papares cited involving animal research have been carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978). Please note that in relation to the nature of the present manuscript (review), study registration/ethics committee approval is not required.</p></notes><notes id="FPar4"><title>Human and Animal Rights and Informed Consent</title><p id="Par43"> This article does not contain any studies with human or animal subjects performed by any of the authors.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing Interests</title><p id="Par44">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><collab>GBD 2019 Mental Disorders Collaborators</collab></person-group><article-title>Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990&#x02013;2019: a systematic analysis for the global burden of Disease Study 2019</article-title><source>Lancet Psychiatry</source><year>2022</year><volume>9</volume><issue>2</issue><fpage>137</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/S2215-0366(21)00395-3</pub-id><pub-id pub-id-type="pmid">35026139</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990&#x02013;2019: a systematic analysis for the global burden of Disease Study 2019. Lancet Psychiatry. 2022;9(2):137&#x02013;50.<pub-id pub-id-type="pmid">35026139</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">WHO. Mental Disorders 2022 [cited 2023 30 May]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/mental-disorders">https://www.who.int/news-room/fact-sheets/detail/mental-disorders</ext-link></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">GBD. In: Global Health Data Exchange. Seattle: Institute for Health Metrics and Evaluation; 2019 [cited 2024 05.03]. Available from: <ext-link ext-link-type="uri" xlink:href="https://vizhub.healthdata.org/gbd-results/?params=gbd-api-2019-permalink/716f37e05d">https://vizhub.healthdata.org/gbd-results/?params=gbd-api-2019-permalink/716f37e05d</ext-link></mixed-citation></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Woody</surname><given-names>CA</given-names></name><name><surname>Ferrari</surname><given-names>AJ</given-names></name><name><surname>Siskind</surname><given-names>DJ</given-names></name><name><surname>Whiteford</surname><given-names>HA</given-names></name><name><surname>Harris</surname><given-names>MG</given-names></name></person-group><article-title>A systematic review and meta-regression of the prevalence and incidence of perinatal depression</article-title><source>J Affect Disord</source><year>2017</year><volume>219</volume><fpage>86</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2017.05.003</pub-id><pub-id pub-id-type="pmid">28531848</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Woody CA, Ferrari AJ, Siskind DJ, Whiteford HA, Harris MG. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J Affect Disord. 2017;219:86&#x02013;92. 10.1016/j.jad.2017.05.003.<pub-id pub-id-type="pmid">28531848</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Evans-Lacko</surname><given-names>S</given-names></name><name><surname>Aguilar-Gaxiola</surname><given-names>S</given-names></name><name><surname>Al-Hamzawi</surname><given-names>A</given-names></name><name><surname>Alonso</surname><given-names>J</given-names></name><name><surname>Benjet</surname><given-names>C</given-names></name><name><surname>Bruffaerts</surname><given-names>R</given-names></name><etal/></person-group><article-title>Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health (WMH) surveys</article-title><source>Psychol Med</source><year>2018</year><volume>48</volume><issue>9</issue><fpage>1560</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1017/S0033291717003336</pub-id><pub-id pub-id-type="pmid">29173244</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Evans-Lacko S, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Benjet C, Bruffaerts R, et al. Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health (WMH) surveys. Psychol Med. 2018;48(9):1560&#x02013;71. 10.1017/S0033291717003336.<pub-id pub-id-type="pmid">29173244</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Olchanski</surname><given-names>N</given-names></name><name><surname>McInnis Myers</surname><given-names>M</given-names></name><name><surname>Halseth</surname><given-names>M</given-names></name><name><surname>Cyr</surname><given-names>PL</given-names></name><name><surname>Bockstedt</surname><given-names>L</given-names></name><name><surname>Goss</surname><given-names>TF</given-names></name><etal/></person-group><article-title>The economic burden of treatment-resistant depression</article-title><source>Clin Ther</source><year>2013</year><volume>35</volume><issue>4</issue><fpage>512</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.clinthera.2012.09.001</pub-id><pub-id pub-id-type="pmid">23490291</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Olchanski N, McInnis Myers M, Halseth M, Cyr PL, Bockstedt L, Goss TF, et al. The economic burden of treatment-resistant depression. Clin Ther. 2013;35(4):512&#x02013;22. 10.1016/j.clinthera.2012.09.001.<pub-id pub-id-type="pmid">23490291</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">WHO. Suicide 2023 [cited 2024 05.04]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/suicide">https://www.who.int/news-room/fact-sheets/detail/suicide</ext-link></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Saloni Dattani L, Rod&#x000e9;s-Guirao H, Ritchie RM. Mental Health 2023 [Available from: <ext-link ext-link-type="uri" xlink:href="https://ourworldindata.org/mental-health">https://ourworldindata.org/mental-health</ext-link></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. American psychiatric association Washington, DC; 2013.</mixed-citation></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Kris-Etherton</surname><given-names>PM</given-names></name><name><surname>Petersen</surname><given-names>KS</given-names></name><name><surname>Hibbeln</surname><given-names>JR</given-names></name><name><surname>Hurley</surname><given-names>D</given-names></name><name><surname>Kolick</surname><given-names>V</given-names></name><name><surname>Peoples</surname><given-names>S</given-names></name><etal/></person-group><article-title>Nutrition and behavioral health disorders: depression and anxiety</article-title><source>Nutr Rev</source><year>2021</year><volume>79</volume><issue>3</issue><fpage>247</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1093/nutrit/nuaa025</pub-id><pub-id pub-id-type="pmid">32447382</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Kris-Etherton PM, Petersen KS, Hibbeln JR, Hurley D, Kolick V, Peoples S, et al. Nutrition and behavioral health disorders: depression and anxiety. Nutr Rev. 2021;79(3):247&#x02013;60. 10.1093/nutrit/nuaa025.<pub-id pub-id-type="pmid">32447382</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Armandpishe</surname><given-names>S</given-names></name><name><surname>Pakzad</surname><given-names>R</given-names></name><name><surname>Jandaghian-Bidgoli</surname><given-names>M</given-names></name><name><surname>Abdi</surname><given-names>F</given-names></name><name><surname>Sardashti</surname><given-names>M</given-names></name><name><surname>Soltaniha</surname><given-names>K</given-names></name></person-group><article-title>Investigating factors affecting the prevalence of stress, anxiety and depression among citizens of Karaj city: a population-based cross-sectional study</article-title><source>Heliyon</source><year>2023</year><volume>9</volume><issue>6</issue><fpage>e16901</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2023.e16901</pub-id><pub-id pub-id-type="pmid">37346360</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Armandpishe S, Pakzad R, Jandaghian-Bidgoli M, Abdi F, Sardashti M, Soltaniha K. Investigating factors affecting the prevalence of stress, anxiety and depression among citizens of Karaj city: a population-based cross-sectional study. Heliyon. 2023;9(6):e16901. 10.1016/j.heliyon.2023.e16901.<pub-id pub-id-type="pmid">37346360</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Adan</surname><given-names>RAH</given-names></name><name><surname>van der Beek</surname><given-names>EM</given-names></name><name><surname>Buitelaar</surname><given-names>JK</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>Hebebrand</surname><given-names>J</given-names></name><name><surname>Higgs</surname><given-names>S</given-names></name><etal/></person-group><article-title>Nutritional psychiatry: towards improving mental health by what you eat</article-title><source>Eur Neuropsychopharmacol</source><year>2019</year><volume>29</volume><issue>12</issue><fpage>1321</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.euroneuro.2019.10.011</pub-id><pub-id pub-id-type="pmid">31735529</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Adan RAH, van der Beek EM, Buitelaar JK, Cryan JF, Hebebrand J, Higgs S, et al. Nutritional psychiatry: towards improving mental health by what you eat. Eur Neuropsychopharmacol. 2019;29(12):1321&#x02013;32. 10.1016/j.euroneuro.2019.10.011.<pub-id pub-id-type="pmid">31735529</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Dinu M, Lotti S, Napoletano A, Corrao A, Pagliai G, Tristan Asensi M, et al. Association between Psychological disorders, Mediterranean Diet, and Chronotype in a group of Italian adults. Int J Environ Res Public Health. 2022;20(1). 10.3390/ijerph20010335.</mixed-citation></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Masana</surname><given-names>MF</given-names></name><name><surname>Haro</surname><given-names>JM</given-names></name><name><surname>Mariolis</surname><given-names>A</given-names></name><name><surname>Piscopo</surname><given-names>S</given-names></name><name><surname>Valacchi</surname><given-names>G</given-names></name><name><surname>Bountziouka</surname><given-names>V</given-names></name><etal/></person-group><article-title>Mediterranean diet and depression among older individuals: the multinational MEDIS study</article-title><source>Exp Gerontol</source><year>2018</year><volume>110</volume><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.exger.2018.05.012</pub-id><pub-id pub-id-type="pmid">29775747</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Masana MF, Haro JM, Mariolis A, Piscopo S, Valacchi G, Bountziouka V, et al. Mediterranean diet and depression among older individuals: the multinational MEDIS study. Exp Gerontol. 2018;110:67&#x02013;72. 10.1016/j.exger.2018.05.012.<pub-id pub-id-type="pmid">29775747</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name></person-group><article-title>Coffee and caffeine consumption and depression: a meta-analysis of observational studies</article-title><source>Aust N Z J Psychiatry</source><year>2016</year><volume>50</volume><issue>3</issue><fpage>228</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1177/0004867415603131</pub-id><pub-id pub-id-type="pmid">26339067</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Wang L, Shen X, Wu Y, Zhang D. Coffee and caffeine consumption and depression: a meta-analysis of observational studies. Aust N Z J Psychiatry. 2016;50(3):228&#x02013;42. 10.1177/0004867415603131.<pub-id pub-id-type="pmid">26339067</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HR</given-names></name><name><surname>Woo</surname><given-names>YS</given-names></name><name><surname>Bahk</surname><given-names>WM</given-names></name></person-group><article-title>Caffeine-induced psychiatric manifestations: a review</article-title><source>Int Clin Psychopharmacol</source><year>2015</year><volume>30</volume><issue>4</issue><fpage>179</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1097/YIC.0000000000000076</pub-id><pub-id pub-id-type="pmid">25856116</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Wang HR, Woo YS, Bahk WM. Caffeine-induced psychiatric manifestations: a review. Int Clin Psychopharmacol. 2015;30(4):179&#x02013;82. 10.1097/YIC.0000000000000076.<pub-id pub-id-type="pmid">25856116</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Lara</surname><given-names>DR</given-names></name></person-group><article-title>Caffeine, mental health, and psychiatric disorders</article-title><source>J Alzheimers Dis</source><year>2010</year><volume>20</volume><issue>Suppl 1</issue><fpage>S239</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.3233/JAD-2010-1378</pub-id><pub-id pub-id-type="pmid">20164571</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Lara DR. Caffeine, mental health, and psychiatric disorders. J Alzheimers Dis. 2010;20(Suppl 1):S239&#x02013;48.<pub-id pub-id-type="pmid">20164571</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">Weinberg BA, Bealer BK. The world of caffeine: the science and culture of the world&#x02019;s most popular drug. Routledge; 2004.</mixed-citation></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Kele&#x0015f;</surname><given-names>F</given-names></name></person-group><article-title>Kafein. Atat&#x000fc;rk &#x000dc;niversitesi</article-title><source>Ziraat Fak&#x000fc;ltesi Dergisi</source><year>2011</year><volume>16</volume><fpage>1</fpage><lpage>4</lpage></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Kele&#x0015f; F. Kafein. Atat&#x000fc;rk &#x000dc;niversitesi. Ziraat Fak&#x000fc;ltesi Dergisi. 2011;16:1&#x02013;4.</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Willson</surname><given-names>C</given-names></name></person-group><article-title>The clinical toxicology of caffeine: a review and case study</article-title><source>Toxicol Rep</source><year>2018</year><volume>5</volume><fpage>1140</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.toxrep.2018.11.002</pub-id><pub-id pub-id-type="pmid">30505695</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Willson C. The clinical toxicology of caffeine: a review and case study. Toxicol Rep. 2018;5:1140&#x02013;52. 10.1016/j.toxrep.2018.11.002.<pub-id pub-id-type="pmid">30505695</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Saud S, Salamatullah AM. Relationship between the Chemical Composition and the Biological functions of Coffee. Molecules. 2021;26(24). 10.3390/molecules26247634.</mixed-citation></ref><ref id="CR124"><label>22.</label><mixed-citation publication-type="other">Y&#x000f6;net Eren F, Ceyhun Sezgin A. Turkish Coffee in Terms of Cultural Heritage. J Turkish Studies. 2018; 13 (10): 697-712.</mixed-citation></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000f6;nder</surname><given-names>M</given-names></name><name><surname>Sanl&#x00131;er</surname><given-names>N</given-names></name></person-group><article-title>Kahve T&#x000fc;ketimi Ve N&#x000f6;rodejeneratif Hastal&#x00131;klarla Iliskisi</article-title><source>Turkiye Klinikleri J Neurol</source><year>2014</year><volume>9</volume><issue>2</issue><fpage>67</fpage><lpage>72</lpage></element-citation><mixed-citation id="mc-CR23" publication-type="journal">G&#x000f6;nder M, Sanl&#x00131;er N. Kahve T&#x000fc;ketimi Ve N&#x000f6;rodejeneratif Hastal&#x00131;klarla Iliskisi. Turkiye Klinikleri J Neurol. 2014;9(2):67&#x02013;72.</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Samanta</surname><given-names>S</given-names></name></person-group><article-title>Potential Bioactive Components and Health Promotional benefits of tea (Camellia sinensis)</article-title><source>J Am Nutr Assoc</source><year>2022</year><volume>41</volume><issue>1</issue><fpage>65</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1080/07315724.2020.1827082</pub-id><pub-id pub-id-type="pmid">33216711</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Samanta S. Potential Bioactive Components and Health Promotional benefits of tea (Camellia sinensis). J Am Nutr Assoc. 2022;41(1):65&#x02013;93. 10.1080/07315724.2020.1827082.<pub-id pub-id-type="pmid">33216711</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Elmas</surname><given-names>C</given-names></name><name><surname>Gezer</surname><given-names>C</given-names></name></person-group><article-title>&#x000c7;ay Bitkisinin (Camellia sinensis) Bile&#x0015f;imi ve Sa&#x0011f;l&#x00131;k Etkileri</article-title><source>Akademik G&#x00131;da</source><year>2019</year><volume>17</volume><issue>3</issue><fpage>417</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.24323/akademik-gida.647733</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Elmas C, Gezer C. &#x000c7;ay Bitkisinin (Camellia sinensis) Bile&#x0015f;imi ve Sa&#x0011f;l&#x00131;k Etkileri. Akademik G&#x00131;da. 2019;17(3):417&#x02013;28. 10.24323/akademik-gida.647733.</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Heckman</surname><given-names>MA</given-names></name><name><surname>Weil</surname><given-names>J</given-names></name><name><surname>Gonzalez de Mejia</surname><given-names>E</given-names></name></person-group><article-title>Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters</article-title><source>J Food Sci</source><year>2010</year><volume>75</volume><issue>3</issue><fpage>R77</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1111/j.1750-3841.2010.01561.x</pub-id><pub-id pub-id-type="pmid">20492310</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Heckman MA, Weil J, Gonzalez de Mejia E. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci. 2010;75(3):R77&#x02013;87. 10.1111/j.1750-3841.2010.01561.x.<pub-id pub-id-type="pmid">20492310</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Verster</surname><given-names>JC</given-names></name><name><surname>Koenig</surname><given-names>J</given-names></name></person-group><article-title>Caffeine intake and its sources: a review of national representative studies</article-title><source>Crit Rev Food Sci Nutr</source><year>2018</year><volume>58</volume><issue>8</issue><fpage>1250</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1080/10408398.2016.1247252</pub-id><pub-id pub-id-type="pmid">28605236</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Verster JC, Koenig J. Caffeine intake and its sources: a review of national representative studies. Crit Rev Food Sci Nutr. 2018;58(8):1250&#x02013;9. 10.1080/10408398.2016.1247252.<pub-id pub-id-type="pmid">28605236</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Nehlig</surname><given-names>A</given-names></name></person-group><article-title>Interindividual Differences in Caffeine Metabolism and factors driving caffeine consumption</article-title><source>Pharmacol Rev</source><year>2018</year><volume>70</volume><issue>2</issue><fpage>384</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1124/pr.117.014407</pub-id><pub-id pub-id-type="pmid">29514871</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Nehlig A. Interindividual Differences in Caffeine Metabolism and factors driving caffeine consumption. Pharmacol Rev. 2018;70(2):384&#x02013;411. 10.1124/pr.117.014407.<pub-id pub-id-type="pmid">29514871</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Barcelos</surname><given-names>RP</given-names></name><name><surname>Lima</surname><given-names>FD</given-names></name><name><surname>Carvalho</surname><given-names>NR</given-names></name><name><surname>Bresciani</surname><given-names>G</given-names></name><name><surname>Royes</surname><given-names>LFF</given-names></name></person-group><article-title>Caffeine effects on systemic metabolism, oxidative-inflammatory pathways, and exercise performance</article-title><source>Nutr Res</source><year>2020</year><volume>80</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2020.05.005</pub-id><pub-id pub-id-type="pmid">32589582</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Barcelos RP, Lima FD, Carvalho NR, Bresciani G, Royes LFF. Caffeine effects on systemic metabolism, oxidative-inflammatory pathways, and exercise performance. Nutr Res. 2020;80:1&#x02013;17. 10.1016/j.nutres.2020.05.005.<pub-id pub-id-type="pmid">32589582</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Hu</surname><given-names>ZY</given-names></name><name><surname>Parker</surname><given-names>RB</given-names></name><name><surname>Laizure</surname><given-names>SC</given-names></name></person-group><article-title>Measurement of caffeine and its three primary metabolites in human plasma by HPLC-ESI&#x02010;MS/MS and clinical application</article-title><source>Biomed Chromatogr</source><year>2017</year><volume>31</volume><issue>6</issue><fpage>e3900</fpage><pub-id pub-id-type="doi">10.1002/bmc.3900</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Chen F, Hu ZY, Parker RB, Laizure SC. Measurement of caffeine and its three primary metabolites in human plasma by HPLC-ESI&#x02010;MS/MS and clinical application. Biomed Chromatogr. 2017;31(6):e3900. 10.1002/bmc.3900.</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="book"><person-group person-group-type="author"><name><surname>Arnaud</surname><given-names>MJ</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Fredholm</surname><given-names>BB</given-names></name></person-group><article-title>Pharmacokinetics and metabolism of natural methylxanthines in Animal and Man</article-title><source>Methylxanthines</source><year>2011</year><publisher-loc>Berlin, Heidelberg</publisher-loc><publisher-name>Springer Berlin Heidelberg</publisher-name><fpage>33</fpage><lpage>91</lpage></element-citation><mixed-citation id="mc-CR31" publication-type="book">Arnaud MJ. Pharmacokinetics and metabolism of natural methylxanthines in Animal and Man. In: Fredholm BB, editor. Methylxanthines. Berlin, Heidelberg: Springer Berlin Heidelberg; 2011. pp. 33&#x02013;91.</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">Arnaud MJ. Components of coffee. Caffeine, coffee, and health. 1993;43.</mixed-citation></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Rousseau</surname><given-names>E</given-names></name><name><surname>Ladine</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>QY</given-names></name><name><surname>Meissner</surname><given-names>G</given-names></name></person-group><article-title>Activation of the Ca2&#x02009;+&#x02009;release channel of skeletal muscle sarcoplasmic reticulum by caffeine and related compounds</article-title><source>Arch Biochem Biophys</source><year>1988</year><volume>267</volume><issue>1</issue><fpage>75</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(88)90010-0</pub-id><pub-id pub-id-type="pmid">2848455</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Rousseau E, Ladine J, Liu QY, Meissner G. Activation of the Ca2&#x02009;+&#x02009;release channel of skeletal muscle sarcoplasmic reticulum by caffeine and related compounds. Arch Biochem Biophys. 1988;267(1):75&#x02013;86. 10.1016/0003-9861(88)90010-0.<pub-id pub-id-type="pmid">2848455</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Nehlig</surname><given-names>A</given-names></name><name><surname>Daval</surname><given-names>J-L</given-names></name><name><surname>Debry</surname><given-names>G</given-names></name></person-group><article-title>Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects</article-title><source>Brain Res Rev</source><year>1992</year><volume>17</volume><issue>2</issue><fpage>139</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/0165-0173(92)90012-B</pub-id><pub-id pub-id-type="pmid">1356551</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Nehlig A, Daval J-L, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev. 1992;17(2):139&#x02013;70. 10.1016/0165-0173(92)90012-B.<pub-id pub-id-type="pmid">1356551</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Cappelletti</surname><given-names>S</given-names></name><name><surname>Piacentino</surname><given-names>D</given-names></name><name><surname>Sani</surname><given-names>G</given-names></name><name><surname>Aromatario</surname><given-names>M</given-names></name></person-group><article-title>Caffeine: cognitive and physical performance enhancer or psychoactive drug?</article-title><source>Curr Neuropharmacol</source><year>2015</year><volume>13</volume><issue>1</issue><fpage>71</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.2174/1570159X13666141210215655</pub-id><pub-id pub-id-type="pmid">26074744</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Cappelletti S, Piacentino D, Sani G, Aromatario M. Caffeine: cognitive and physical performance enhancer or psychoactive drug? Curr Neuropharmacol. 2015;13(1):71&#x02013;88. 10.2174/1570159X13666141210215655.<pub-id pub-id-type="pmid">26074744</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Daly</surname><given-names>JW</given-names></name><name><surname>Shi</surname><given-names>D</given-names></name><name><surname>Nikodijevic</surname><given-names>O</given-names></name><name><surname>Jacobson</surname><given-names>KA</given-names></name></person-group><article-title>The role of adenosine receptors in the central action of caffeine</article-title><source>Pharmacopsychoecologia</source><year>1994</year><volume>7</volume><issue>2</issue><fpage>201</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">25821357</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Daly JW, Shi D, Nikodijevic O, Jacobson KA. The role of adenosine receptors in the central action of caffeine. Pharmacopsychoecologia. 1994;7(2):201&#x02013;13.<pub-id pub-id-type="pmid">25821357</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>JP</given-names></name><name><surname>Pli&#x000e1;ssova</surname><given-names>A</given-names></name><name><surname>Cunha</surname><given-names>RA</given-names></name></person-group><article-title>The physiological effects of caffeine on synaptic transmission and plasticity in the mouse hippocampus selectively depend on adenosine A(1) and A(2A) receptors</article-title><source>Biochem Pharmacol</source><year>2019</year><volume>166</volume><fpage>313</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2019.06.008</pub-id><pub-id pub-id-type="pmid">31199895</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Lopes JP, Pli&#x000e1;ssova A, Cunha RA. The physiological effects of caffeine on synaptic transmission and plasticity in the mouse hippocampus selectively depend on adenosine A(1) and A(2A) receptors. Biochem Pharmacol. 2019;166:313&#x02013;21.<pub-id pub-id-type="pmid">31199895</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Saini</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>R</given-names></name><name><surname>Gaba</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>G</given-names></name><name><surname>Gupta</surname><given-names>GD</given-names></name><name><surname>Monga</surname><given-names>V</given-names></name></person-group><article-title>Adenosine receptor antagonists: recent advances and therapeutic perspective</article-title><source>Eur J Med Chem</source><year>2022</year><volume>227</volume><fpage>113907</fpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2021.113907</pub-id><pub-id pub-id-type="pmid">34695776</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Saini A, Patel R, Gaba S, Singh G, Gupta GD, Monga V. Adenosine receptor antagonists: recent advances and therapeutic perspective. Eur J Med Chem. 2022;227:113907. 10.1016/j.ejmech.2021.113907.<pub-id pub-id-type="pmid">34695776</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="other">Urrialde R. Caffeine. In: Caballero B, editor. Encyclopedia of Human Nutrition (Fourth Edition). Oxford: Academic Press; 2023. pp. 96&#x02013;104.</mixed-citation></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><etal/></person-group><article-title>40 hz light flickering promotes sleep through cortical adenosine signaling</article-title><source>Cell Res</source><year>2024</year><volume>34</volume><issue>3</issue><fpage>214</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1038/s41422-023-00920-1</pub-id><pub-id pub-id-type="pmid">38332199</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Zhou X, He Y, Xu T, Wu Z, Guo W, Xu X, et al. 40 hz light flickering promotes sleep through cortical adenosine signaling. Cell Res. 2024;34(3):214&#x02013;31. 10.1038/s41422-023-00920-1.<pub-id pub-id-type="pmid">38332199</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="other">Korkutata M, Lazarus M, Adenosine. A(2A) receptors and sleep. Int Rev Neurobiol. 2023;170:155&#x02013;78.</mixed-citation></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Dias</surname><given-names>L</given-names></name><name><surname>Peng</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Ge</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>40 hz light flickering facilitates the glymphatic flow via adenosine signaling in mice</article-title><source>Cell Discovery</source><year>2024</year><volume>10</volume><issue>1</issue><fpage>81</fpage><pub-id pub-id-type="doi">10.1038/s41421-024-00701-z</pub-id><pub-id pub-id-type="pmid">39103336</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Sun X, Dias L, Peng C, Zhang Z, Ge H, Wang Z, et al. 40 hz light flickering facilitates the glymphatic flow via adenosine signaling in mice. Cell Discovery. 2024;10(1):81. 10.1038/s41421-024-00701-z.<pub-id pub-id-type="pmid">39103336</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>I</given-names></name><name><surname>Landolt</surname><given-names>HP</given-names></name></person-group><article-title>Coffee, caffeine, and sleep: a systematic review of epidemiological studies and randomized controlled trials</article-title><source>Sleep Med Rev</source><year>2017</year><volume>31</volume><fpage>70</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.smrv.2016.01.006</pub-id><pub-id pub-id-type="pmid">26899133</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Clark I, Landolt HP. Coffee, caffeine, and sleep: a systematic review of epidemiological studies and randomized controlled trials. Sleep Med Rev. 2017;31:70&#x02013;8. <ext-link ext-link-type="uri" xlink:href="https://www.sciencedirect.com/science/article/pii/S1087079216000150">https://www.sciencedirect.com/science/article/pii/S1087079216000150</ext-link>.<pub-id pub-id-type="pmid">26899133</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="other">Temple JL, Review. Trends, Safety, and recommendations for Caffeine Use in Children and adolescents. J Am Acad Child Adolesc Psychiatry. 2019;58(1):36&#x02013;45. 10.1016/j.jaac.2018.06.030.</mixed-citation></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Iris</surname><given-names>M</given-names></name><name><surname>Tsou</surname><given-names>PS</given-names></name><name><surname>Sawalha</surname><given-names>AH</given-names></name></person-group><article-title>Caffeine inhibits STAT1 signaling and downregulates inflammatory pathways involved in autoimmunity</article-title><source>Clin Immunol</source><year>2018</year><volume>192</volume><fpage>68</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.clim.2018.04.008</pub-id><pub-id pub-id-type="pmid">29678503</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Iris M, Tsou PS, Sawalha AH. Caffeine inhibits STAT1 signaling and downregulates inflammatory pathways involved in autoimmunity. Clin Immunol. 2018;192:68&#x02013;77. 10.1016/j.clim.2018.04.008.<pub-id pub-id-type="pmid">29678503</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Kolahdouzan</surname><given-names>M</given-names></name><name><surname>Hamadeh</surname><given-names>MJ</given-names></name></person-group><article-title>The neuroprotective effects of caffeine in neurodegenerative diseases</article-title><source>CNS Neurosci Ther</source><year>2017</year><volume>23</volume><issue>4</issue><fpage>272</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1111/cns.12684</pub-id><pub-id pub-id-type="pmid">28317317</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Kolahdouzan M, Hamadeh MJ. The neuroprotective effects of caffeine in neurodegenerative diseases. CNS Neurosci Ther. 2017;23(4):272&#x02013;90. 10.1111/cns.12684.<pub-id pub-id-type="pmid">28317317</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Poole</surname><given-names>R</given-names></name><name><surname>Kennedy</surname><given-names>OJ</given-names></name><name><surname>Roderick</surname><given-names>P</given-names></name><name><surname>Fallowfield</surname><given-names>JA</given-names></name><name><surname>Hayes</surname><given-names>PC</given-names></name><name><surname>Parkes</surname><given-names>J</given-names></name></person-group><article-title>Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes</article-title><source>BMJ</source><year>2017</year><volume>359</volume><fpage>j5024</fpage><pub-id pub-id-type="doi">10.1136/bmj.j5024</pub-id><pub-id pub-id-type="pmid">29167102</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017;359:j5024. 10.1136/bmj.j5024.<pub-id pub-id-type="pmid">29167102</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Salk</surname><given-names>RH</given-names></name><name><surname>Hyde</surname><given-names>JS</given-names></name><name><surname>Abramson</surname><given-names>LY</given-names></name></person-group><article-title>Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms</article-title><source>Psychol Bull</source><year>2017</year><volume>143</volume><issue>8</issue><fpage>783</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1037/bul0000102</pub-id><pub-id pub-id-type="pmid">28447828</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Salk RH, Hyde JS, Abramson LY. Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms. Psychol Bull. 2017;143(8):783&#x02013;822. 10.1037/bul0000102.<pub-id pub-id-type="pmid">28447828</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Goodwin</surname><given-names>RD</given-names></name><name><surname>Dierker</surname><given-names>LC</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Galea</surname><given-names>S</given-names></name><name><surname>Hoven</surname><given-names>CW</given-names></name><name><surname>Weinberger</surname><given-names>AH</given-names></name></person-group><article-title>Trends in U.S. Depression Prevalence from 2015 to 2020: the Widening Treatment Gap</article-title><source>Am J Prev Med</source><year>2022</year><volume>63</volume><issue>5</issue><fpage>726</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.amepre.2022.05.014</pub-id><pub-id pub-id-type="pmid">36272761</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Goodwin RD, Dierker LC, Wu M, Galea S, Hoven CW, Weinberger AH. Trends in U.S. Depression Prevalence from 2015 to 2020: the Widening Treatment Gap. Am J Prev Med. 2022;63(5):726&#x02013;33. 10.1016/j.amepre.2022.05.014.<pub-id pub-id-type="pmid">36272761</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">American Psychiatric Association. What Is Depression? 2024 [cited 2024 02.01]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.psychiatry.org/patients-families/depression/what-is-depression#section_1">https://www.psychiatry.org/patients-families/depression/what-is-depression#section_1</ext-link></mixed-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="other">WHO. Depressive Dissorders (Depression) 2023 [cited 2024 02.01]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/depression">https://www.who.int/news-room/fact-sheets/detail/depression</ext-link></mixed-citation></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Jesulola</surname><given-names>E</given-names></name><name><surname>Micalos</surname><given-names>P</given-names></name><name><surname>Baguley</surname><given-names>IJ</given-names></name></person-group><article-title>Understanding the pathophysiology of depression: from monoamines to the neurogenesis hypothesis model - are we there yet?</article-title><source>Behav Brain Res</source><year>2018</year><volume>341</volume><fpage>79</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2017.12.025</pub-id><pub-id pub-id-type="pmid">29284108</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Jesulola E, Micalos P, Baguley IJ. Understanding the pathophysiology of depression: from monoamines to the neurogenesis hypothesis model - are we there yet? Behav Brain Res. 2018;341:79&#x02013;90. 10.1016/j.bbr.2017.12.025.<pub-id pub-id-type="pmid">29284108</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Brigitta</surname><given-names>B</given-names></name></person-group><article-title>Pathophysiology of depression and mechanisms of treatment</article-title><source>Dialogues Clin Neurosci</source><year>2002</year><volume>4</volume><issue>1</issue><fpage>7</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.31887/DCNS.2002.4.1/bbondy</pub-id><pub-id pub-id-type="pmid">22033824</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Brigitta B. Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci. 2002;4(1):7&#x02013;20. 10.31887/DCNS.2002.4.1/bbondy.<pub-id pub-id-type="pmid">22033824</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Alasmari</surname><given-names>F</given-names></name></person-group><article-title>Caffeine induces neurobehavioral effects through modulating neurotransmitters</article-title><source>Saudi Pharm J</source><year>2020</year><volume>28</volume><issue>4</issue><fpage>445</fpage><pub-id pub-id-type="doi">10.1016/j.jsps.2020.02.005</pub-id><pub-id pub-id-type="pmid">32273803</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Alasmari F. Caffeine induces neurobehavioral effects through modulating neurotransmitters. Saudi Pharm J. 2020;28(4):445&#x02013;. 10.1016/j.jsps.2020.02.005. &#x02009;51.<pub-id pub-id-type="pmid">32273803</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>van Calker</surname><given-names>D</given-names></name><name><surname>Biber</surname><given-names>K</given-names></name><name><surname>Domschke</surname><given-names>K</given-names></name><name><surname>Serchov</surname><given-names>T</given-names></name></person-group><article-title>The role of adenosine receptors in mood and anxiety disorders</article-title><source>J Neurochem</source><year>2019</year><volume>151</volume><issue>1</issue><fpage>11</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1111/jnc.14841</pub-id><pub-id pub-id-type="pmid">31361031</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">van Calker D, Biber K, Domschke K, Serchov T. The role of adenosine receptors in mood and anxiety disorders. J Neurochem. 2019;151(1):11&#x02013;27.<pub-id pub-id-type="pmid">31361031</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Cunha</surname><given-names>RA</given-names></name></person-group><article-title>How does adenosine control neuronal dysfunction and neurodegeneration?</article-title><source>J Neurochem</source><year>2016</year><volume>139</volume><issue>6</issue><fpage>1019</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1111/jnc.13724</pub-id><pub-id pub-id-type="pmid">27365148</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Cunha RA. How does adenosine control neuronal dysfunction and neurodegeneration? J Neurochem. 2016;139(6):1019&#x02013;55.<pub-id pub-id-type="pmid">27365148</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez-Cruz</surname><given-names>L</given-names></name><name><surname>Salamone</surname><given-names>JD</given-names></name><name><surname>Correa</surname><given-names>M</given-names></name></person-group><article-title>Caffeine and selective adenosine receptor antagonists as new therapeutic tools for the motivational symptoms of depression</article-title><source>Front Pharmacol</source><year>2018</year><volume>9</volume><fpage>526</fpage><pub-id pub-id-type="doi">10.3389/fphar.2018.00526</pub-id><pub-id pub-id-type="pmid">29910727</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">L&#x000f3;pez-Cruz L, Salamone JD, Correa M. Caffeine and selective adenosine receptor antagonists as new therapeutic tools for the motivational symptoms of depression. Front Pharmacol. 2018;9:526. 10.3389/fphar.2018.00526.<pub-id pub-id-type="pmid">29910727</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Iranpour</surname><given-names>S</given-names></name><name><surname>Sabour</surname><given-names>S</given-names></name></person-group><article-title>Inverse association between caffeine intake and depressive symptoms in US adults: data from National Health and Nutrition Examination Survey (NHANES) 2005&#x02013;2006</article-title><source>Psychiatry Res</source><year>2019</year><volume>271</volume><fpage>732</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.psychres.2018.11.004</pub-id><pub-id pub-id-type="pmid">30791349</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Iranpour S, Sabour S. Inverse association between caffeine intake and depressive symptoms in US adults: data from National Health and Nutrition Examination Survey (NHANES) 2005&#x02013;2006. Psychiatry Res. 2019;271:732&#x02013;9. 10.1016/j.psychres.2018.11.004.<pub-id pub-id-type="pmid">30791349</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>dePaula</surname><given-names>J</given-names></name><name><surname>Farah</surname><given-names>A</given-names></name></person-group><article-title>Caffeine consumption through coffee: content in the Beverage, Metabolism, Health benefits and risks</article-title><source>Beverages</source><year>2019</year><volume>5</volume><issue>2</issue><fpage>37</fpage><pub-id pub-id-type="doi">10.3390/beverages5020037</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">dePaula J, Farah A. Caffeine consumption through coffee: content in the Beverage, Metabolism, Health benefits and risks. Beverages. 2019;5(2):37. <ext-link ext-link-type="uri" xlink:href="https://www.mdpi.com/2306-5710/5/2/37">https://www.mdpi.com/2306-5710/5/2/37</ext-link>.</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="other">EFSA Panel on Dietetic Products N, Allergies. Scientific opinion on the safety of caffeine. EFSA J. 2015;13(5):4102. <ext-link ext-link-type="uri" xlink:href="https://efsa.onlinelibrary.wiley.com/doi/abs/10.2903/j.efsa.2015.4102">https://efsa.onlinelibrary.wiley.com/doi/abs/10.2903/j.efsa.2015.4102</ext-link>.</mixed-citation></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>NJ</given-names></name><name><surname>Sim&#x000f5;es</surname><given-names>AP</given-names></name><name><surname>Silva</surname><given-names>HB</given-names></name><name><surname>Ardais</surname><given-names>AP</given-names></name><name><surname>Kaster</surname><given-names>MP</given-names></name><name><surname>Gar&#x000e7;&#x000e3;o</surname><given-names>P</given-names></name><etal/></person-group><article-title>Caffeine reverts memory but not mood impairment in a depression-prone mouse strain with up-regulated adenosine a 2A receptor in hippocampal glutamate synapses</article-title><source>Mol Neurobiol</source><year>2017</year><volume>54</volume><fpage>1552</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1007/s12035-016-9774-9</pub-id><pub-id pub-id-type="pmid">26860412</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Machado NJ, Sim&#x000f5;es AP, Silva HB, Ardais AP, Kaster MP, Gar&#x000e7;&#x000e3;o P, et al. Caffeine reverts memory but not mood impairment in a depression-prone mouse strain with up-regulated adenosine a 2A receptor in hippocampal glutamate synapses. Mol Neurobiol. 2017;54:1552&#x02013;63. 10.1007/s12035-016-9774-9.<pub-id pub-id-type="pmid">26860412</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Volkow</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Logan</surname><given-names>J</given-names></name><name><surname>Alexoff</surname><given-names>D</given-names></name><name><surname>Fowler</surname><given-names>J</given-names></name><name><surname>Thanos</surname><given-names>P</given-names></name><etal/></person-group><article-title>Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain</article-title><source>Translational Psychiatry</source><year>2015</year><volume>5</volume><issue>4</issue><fpage>e549</fpage><lpage>e</lpage><pub-id pub-id-type="doi">10.1038/tp.2015.46</pub-id><pub-id pub-id-type="pmid">25871974</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Volkow N, Wang G, Logan J, Alexoff D, Fowler J, Thanos P, et al. Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain. Translational Psychiatry. 2015;5(4):e549&#x02013;e. 10.1038/tp.2015.46.<pub-id pub-id-type="pmid">25871974</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Kubera</surname><given-names>M</given-names></name><name><surname>Obuchowicz</surname><given-names>E</given-names></name><name><surname>Goehler</surname><given-names>L</given-names></name><name><surname>Brzeszcz</surname><given-names>J</given-names></name><name><surname>Maes</surname><given-names>M</given-names></name></person-group><article-title>In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression</article-title><source>Prog Neuropsychopharmacol Biol Psychiatry</source><year>2011</year><volume>35</volume><issue>3</issue><fpage>744</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.pnpbp.2010.08.026</pub-id><pub-id pub-id-type="pmid">20828592</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(3):744&#x02013;59.<pub-id pub-id-type="pmid">20828592</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>ZF</given-names></name><name><surname>Ouyang</surname><given-names>SH</given-names></name><name><surname>Zhang</surname><given-names>QY</given-names></name><name><surname>Wu</surname><given-names>YP</given-names></name><name><surname>Wang</surname><given-names>GE</given-names></name><name><surname>Tu</surname><given-names>LF</given-names></name><etal/></person-group><article-title>New insights into the effects of caffeine on adult hippocampal neurogenesis in stressed mice: inhibition of CORT-induced microglia activation</article-title><source>Faseb j</source><year>2020</year><volume>34</volume><issue>8</issue><fpage>10998</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1096/fj.202000146RR</pub-id><pub-id pub-id-type="pmid">32619083</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Mao ZF, Ouyang SH, Zhang QY, Wu YP, Wang GE, Tu LF, et al. New insights into the effects of caffeine on adult hippocampal neurogenesis in stressed mice: inhibition of CORT-induced microglia activation. Faseb j. 2020;34(8):10998&#x02013;1014.<pub-id pub-id-type="pmid">32619083</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Smolinski</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>J</given-names></name></person-group><article-title>Caffeine is negatively associated with depression in patients aged 20 and older</article-title><source>Front Psychiatry</source><year>2022</year><volume>13</volume><fpage>1037579</fpage><pub-id pub-id-type="doi">10.3389/fpsyt.2022.1037579</pub-id><pub-id pub-id-type="pmid">36532163</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Bao J, Li P, Guo Y, Zheng Y, Smolinski M, He J. Caffeine is negatively associated with depression in patients aged 20 and older. Front Psychiatry. 2022;13:1037579. 10.3389/fpsyt.2022.1037579.<pub-id pub-id-type="pmid">36532163</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Basu Mallik</surname><given-names>S</given-names></name><name><surname>Mudgal</surname><given-names>J</given-names></name><name><surname>Hall</surname><given-names>S</given-names></name><name><surname>Kinra</surname><given-names>M</given-names></name><name><surname>Grant</surname><given-names>GD</given-names></name><name><surname>Nampoothiri</surname><given-names>M</given-names></name><etal/></person-group><article-title>Remedial effects of caffeine against depressive-like behaviour in mice by modulation of neuroinflammation and BDNF</article-title><source>Nutr Neurosci</source><year>2022</year><volume>25</volume><issue>9</issue><fpage>1836</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1080/1028415X.2021.1906393</pub-id><pub-id pub-id-type="pmid">33814004</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Basu Mallik S, Mudgal J, Hall S, Kinra M, Grant GD, Nampoothiri M, et al. Remedial effects of caffeine against depressive-like behaviour in mice by modulation of neuroinflammation and BDNF. Nutr Neurosci. 2022;25(9):1836&#x02013;44. 10.1080/1028415X.2021.1906393.<pub-id pub-id-type="pmid">33814004</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><mixed-citation publication-type="other">Navarro AM, Abasheva D, Mart&#x000ed;nez-Gonz&#x000e1;lez M, Ruiz-Estigarribia L, Mart&#x000ed;n-Calvo N, S&#x000e1;nchez-Villegas A, et al. Coffee Consumption and the risk of Depression in a middle-aged cohort: the SUN Project. Nutrients. 2018;10(9). 10.3390/nu10091333.</mixed-citation></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Asil</surname><given-names>E</given-names></name><name><surname>Y&#x00131;lmaz</surname><given-names>MV</given-names></name><name><surname>Yardimci</surname><given-names>H</given-names></name></person-group><article-title>Effects of black tea consumption and caffeine intake on depression risk in black tea consumers</article-title><source>Afr Health Sci</source><year>2021</year><volume>21</volume><issue>2</issue><fpage>858</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.4314/ahs.v21i2.47</pub-id><pub-id pub-id-type="pmid">34795745</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Asil E, Y&#x00131;lmaz MV, Yardimci H. Effects of black tea consumption and caffeine intake on depression risk in black tea consumers. Afr Health Sci. 2021;21(2):858&#x02013;65. 10.4314/ahs.v21i2.47.<pub-id pub-id-type="pmid">34795745</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><mixed-citation publication-type="other">Kim J, Kim J, Green Tea. Coffee, and Caffeine Consumption are inversely Associated with Self-Report Lifetime Depression in the Korean Population. Nutrients. 2018;10(9). 10.3390/nu10091201.</mixed-citation></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Pic&#x000f3;-P&#x000e9;rez</surname><given-names>M</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>R</given-names></name><name><surname>Esteves</surname><given-names>M</given-names></name><name><surname>Vieira</surname><given-names>R</given-names></name><name><surname>Castanho</surname><given-names>TC</given-names></name><name><surname>Amorim</surname><given-names>L</given-names></name><etal/></person-group><article-title>Coffee consumption decreases the connectivity of the posterior default Mode Network (DMN) at rest</article-title><source>Front Behav Neurosci</source><year>2023</year><volume>17</volume><fpage>1176382</fpage><pub-id pub-id-type="doi">10.3389/fnbeh.2023.1176382</pub-id><pub-id pub-id-type="pmid">37448789</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">Pic&#x000f3;-P&#x000e9;rez M, Magalh&#x000e3;es R, Esteves M, Vieira R, Castanho TC, Amorim L, et al. Coffee consumption decreases the connectivity of the posterior default Mode Network (DMN) at rest. Front Behav Neurosci. 2023;17:1176382.<pub-id pub-id-type="pmid">37448789</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Magalh&#x000e3;es</surname><given-names>R</given-names></name><name><surname>Pic&#x000f3;-P&#x000e9;rez</surname><given-names>M</given-names></name><name><surname>Esteves</surname><given-names>M</given-names></name><name><surname>Vieira</surname><given-names>R</given-names></name><name><surname>Castanho</surname><given-names>TC</given-names></name><name><surname>Amorim</surname><given-names>L</given-names></name><etal/></person-group><article-title>Habitual coffee drinkers display a distinct pattern of brain functional connectivity</article-title><source>Mol Psychiatry</source><year>2021</year><volume>26</volume><issue>11</issue><fpage>6589</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1038/s41380-021-01075-4</pub-id><pub-id pub-id-type="pmid">33875801</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Magalh&#x000e3;es R, Pic&#x000f3;-P&#x000e9;rez M, Esteves M, Vieira R, Castanho TC, Amorim L, et al. Habitual coffee drinkers display a distinct pattern of brain functional connectivity. Mol Psychiatry. 2021;26(11):6589&#x02013;98.<pub-id pub-id-type="pmid">33875801</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><etal/></person-group><article-title>Prevalence of depression in older adults: a systematic review and meta-analysis</article-title><source>Psychiatry Res</source><year>2022</year><volume>311</volume><fpage>114511</fpage><pub-id pub-id-type="doi">10.1016/j.psychres.2022.114511</pub-id><pub-id pub-id-type="pmid">35316691</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Hu T, Zhao X, Wu M, Li Z, Luo L, Yang C, et al. Prevalence of depression in older adults: a systematic review and meta-analysis. Psychiatry Res. 2022;311:114511. <ext-link ext-link-type="uri" xlink:href="https://www.sciencedirect.com/science/article/pii/S0165178122001251">https://www.sciencedirect.com/science/article/pii/S0165178122001251</ext-link>.<pub-id pub-id-type="pmid">35316691</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>CR</given-names></name><name><surname>Cunha</surname><given-names>RA</given-names></name></person-group><article-title>Impact of coffee intake on human aging: epidemiology and cellular mechanisms</article-title><source>Ageing Res Rev</source><year>2024</year><volume>102</volume><fpage>102581</fpage><pub-id pub-id-type="doi">10.1016/j.arr.2024.102581</pub-id><pub-id pub-id-type="pmid">39557300</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Lopes CR, Cunha RA. Impact of coffee intake on human aging: epidemiology and cellular mechanisms. Ageing Res Rev. 2024;102:102581.<pub-id pub-id-type="pmid">39557300</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Ye</surname><given-names>N</given-names></name><name><surname>He</surname><given-names>X</given-names></name></person-group><article-title>From cup to clock: exploring coffee&#x02019;s role in slowing down biological aging</article-title><source>Food Funct</source><year>2024</year><volume>15</volume><issue>10</issue><fpage>5655</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1039/D3FO04177H</pub-id><pub-id pub-id-type="pmid">38726849</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Chen X, Yin X, Gao Y, Chen X, Ye N, He X. From cup to clock: exploring coffee&#x02019;s role in slowing down biological aging. Food Funct. 2024;15(10):5655&#x02013;63.<pub-id pub-id-type="pmid">38726849</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Lucas</surname><given-names>M</given-names></name><name><surname>O&#x02019;Reilly</surname><given-names>EJ</given-names></name><name><surname>Pan</surname><given-names>A</given-names></name><name><surname>Mirzaei</surname><given-names>F</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Okereke</surname><given-names>OI</given-names></name><etal/></person-group><article-title>Coffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults</article-title><source>World J Biol Psychiatry</source><year>2014</year><volume>15</volume><issue>5</issue><fpage>377</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.3109/15622975.2013.795243</pub-id><pub-id pub-id-type="pmid">23819683</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Lucas M, O&#x02019;Reilly EJ, Pan A, Mirzaei F, Willett WC, Okereke OI, et al. Coffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults. World J Biol Psychiatry. 2014;15(5):377&#x02013;86.<pub-id pub-id-type="pmid">23819683</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>SA</given-names></name><name><surname>Park</surname><given-names>EC</given-names></name></person-group><article-title>Association between energy drink consumption, depression and suicide ideation in Korean adolescents</article-title><source>Int J Soc Psychiatry</source><year>2020</year><volume>66</volume><issue>4</issue><fpage>335</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1177/0020764020907946</pub-id><pub-id pub-id-type="pmid">32114878</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Kim H, Park J, Lee S, Lee SA, Park EC. Association between energy drink consumption, depression and suicide ideation in Korean adolescents. Int J Soc Psychiatry. 2020;66(4):335&#x02013;43.<pub-id pub-id-type="pmid">32114878</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Torabynasab</surname><given-names>K</given-names></name><name><surname>Shahinfar</surname><given-names>H</given-names></name><name><surname>Payandeh</surname><given-names>N</given-names></name><name><surname>Jazayeri</surname><given-names>S</given-names></name></person-group><article-title>Association between dietary caffeine, coffee, and tea consumption and depressive symptoms in adults: a systematic review and dose-response meta-analysis of observational studies</article-title><source>Front Nutr</source><year>2023</year><volume>10</volume><fpage>1051444</fpage><pub-id pub-id-type="doi">10.3389/fnut.2023.1051444</pub-id><pub-id pub-id-type="pmid">36845051</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Torabynasab K, Shahinfar H, Payandeh N, Jazayeri S. Association between dietary caffeine, coffee, and tea consumption and depressive symptoms in adults: a systematic review and dose-response meta-analysis of observational studies. Front Nutr. 2023;10:1051444. 10.3389/fnut.2023.1051444.<pub-id pub-id-type="pmid">36845051</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Pogoda</surname><given-names>JM</given-names></name><name><surname>Patricio</surname><given-names>G</given-names></name><name><surname>McEligot</surname><given-names>AJ</given-names></name></person-group><article-title>Association between Caffeine Consumption and Depression in NHANES 2009&#x02013;2010</article-title><source>Calif J Health Promot</source><year>2018</year><volume>16</volume><issue>1</issue><fpage>16</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.32398/cjhp.v16i1.2120</pub-id><pub-id pub-id-type="pmid">30853870</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Pogoda JM, Patricio G, McEligot AJ. Association between Caffeine Consumption and Depression in NHANES 2009&#x02013;2010. Calif J Health Promot. 2018;16(1):16&#x02013;23.<pub-id pub-id-type="pmid">30853870</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Szopa</surname><given-names>A</given-names></name><name><surname>Poleszak</surname><given-names>E</given-names></name><name><surname>Wyska</surname><given-names>E</given-names></name><name><surname>Serefko</surname><given-names>A</given-names></name><name><surname>Wo&#x0015b;ko</surname><given-names>S</given-names></name><name><surname>Wla&#x0017a;</surname><given-names>A</given-names></name><etal/></person-group><article-title>Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice</article-title><source>Naunyn Schmiedebergs Arch Pharmacol</source><year>2016</year><volume>389</volume><issue>2</issue><fpage>211</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1007/s00210-015-1189-z</pub-id><pub-id pub-id-type="pmid">26614569</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Szopa A, Poleszak E, Wyska E, Serefko A, Wo&#x0015b;ko S, Wla&#x0017a; A, et al. Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice. Naunyn Schmiedebergs Arch Pharmacol. 2016;389(2):211&#x02013;21. 10.1007/s00210-015-1189-z.<pub-id pub-id-type="pmid">26614569</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>S</given-names></name><name><surname>Ardais</surname><given-names>AP</given-names></name><name><surname>Bastos</surname><given-names>CR</given-names></name><name><surname>Gazal</surname><given-names>M</given-names></name><name><surname>Jansen</surname><given-names>K</given-names></name><name><surname>de Mattos Souza</surname><given-names>L</given-names></name><etal/></person-group><article-title>Impact of genetic variations in ADORA2A gene on depression and symptoms: a cross-sectional population-based study</article-title><source>Purinergic Signal</source><year>2019</year><volume>15</volume><issue>1</issue><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1007/s11302-018-9635-2</pub-id><pub-id pub-id-type="pmid">30511252</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Oliveira S, Ardais AP, Bastos CR, Gazal M, Jansen K, de Mattos Souza L, et al. Impact of genetic variations in ADORA2A gene on depression and symptoms: a cross-sectional population-based study. Purinergic Signal. 2019;15(1):37&#x02013;44.<pub-id pub-id-type="pmid">30511252</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name><surname>Gass</surname><given-names>N</given-names></name><name><surname>Ollila</surname><given-names>HM</given-names></name><name><surname>Utge</surname><given-names>S</given-names></name><name><surname>Partonen</surname><given-names>T</given-names></name><name><surname>Kronholm</surname><given-names>E</given-names></name><name><surname>Pirkola</surname><given-names>S</given-names></name><etal/></person-group><article-title>Contribution of adenosine related genes to the risk of depression with disturbed sleep</article-title><source>J Affect Disord</source><year>2010</year><volume>126</volume><issue>1&#x02013;2</issue><fpage>134</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2010.03.009</pub-id><pub-id pub-id-type="pmid">20392501</pub-id>
</element-citation><mixed-citation id="mc-CR81" publication-type="journal">Gass N, Ollila HM, Utge S, Partonen T, Kronholm E, Pirkola S, et al. Contribution of adenosine related genes to the risk of depression with disturbed sleep. J Affect Disord. 2010;126(1&#x02013;2):134&#x02013;9.<pub-id pub-id-type="pmid">20392501</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>LS</given-names></name><name><surname>Zhang</surname><given-names>ZY</given-names></name><name><surname>Yan</surname><given-names>LJ</given-names></name><name><surname>Yan</surname><given-names>YC</given-names></name><name><surname>Tan</surname><given-names>SY</given-names></name><name><surname>Wang</surname><given-names>DX</given-names></name><etal/></person-group><article-title>Caffeine intake is associated with less severe depressive symptoms in noncancer populations: an analysis based on NHANES 2007&#x02013;2016</article-title><source>Nutr Res</source><year>2023</year><volume>118</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2023.07.004</pub-id><pub-id pub-id-type="pmid">37531810</pub-id>
</element-citation><mixed-citation id="mc-CR82" publication-type="journal">Yang LS, Zhang ZY, Yan LJ, Yan YC, Tan SY, Wang DX, et al. Caffeine intake is associated with less severe depressive symptoms in noncancer populations: an analysis based on NHANES 2007&#x02013;2016. Nutr Res. 2023;118:1&#x02013;11. 10.1016/j.nutres.2023.07.004.<pub-id pub-id-type="pmid">37531810</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name><surname>Pham</surname><given-names>NM</given-names></name><name><surname>Nanri</surname><given-names>A</given-names></name><name><surname>Kurotani</surname><given-names>K</given-names></name><name><surname>Kuwahara</surname><given-names>K</given-names></name><name><surname>Kume</surname><given-names>A</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name><etal/></person-group><article-title>Green tea and coffee consumption is inversely associated with depressive symptoms in a Japanese working population</article-title><source>Public Health Nutr</source><year>2014</year><volume>17</volume><issue>3</issue><fpage>625</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1017/S1368980013000360</pub-id><pub-id pub-id-type="pmid">23453038</pub-id>
</element-citation><mixed-citation id="mc-CR83" publication-type="journal">Pham NM, Nanri A, Kurotani K, Kuwahara K, Kume A, Sato M, et al. Green tea and coffee consumption is inversely associated with depressive symptoms in a Japanese working population. Public Health Nutr. 2014;17(3):625&#x02013;33. 10.1017/S1368980013000360.<pub-id pub-id-type="pmid">23453038</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name><surname>Plumber</surname><given-names>N</given-names></name><name><surname>Majeed</surname><given-names>M</given-names></name><name><surname>Ziff</surname><given-names>S</given-names></name><name><surname>Thomas</surname><given-names>SE</given-names></name><name><surname>Bolla</surname><given-names>SR</given-names></name><name><surname>Gorantla</surname><given-names>VR</given-names></name></person-group><article-title>Stimulant usage by medical students for cognitive enhancement: a systematic review</article-title><source>Cureus</source><year>2021</year><volume>13</volume><issue>5</issue><fpage>e15163</fpage><pub-id pub-id-type="doi">10.7759/cureus.15163</pub-id><pub-id pub-id-type="pmid">34178492</pub-id>
</element-citation><mixed-citation id="mc-CR84" publication-type="journal">Plumber N, Majeed M, Ziff S, Thomas SE, Bolla SR, Gorantla VR. Stimulant usage by medical students for cognitive enhancement: a systematic review. Cureus. 2021;13(5):e15163. 10.7759/cureus.15163.<pub-id pub-id-type="pmid">34178492</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><mixed-citation publication-type="other">Jee HJ, Lee SG, Bormate KJ, Jung YS. Effect of Caffeine Consumption on the risk for Neurological and Psychiatric disorders: sex differences in human. Nutrients. 2020;12(10). 10.3390/nu12103080.</mixed-citation></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name><surname>Jha</surname><given-names>PK</given-names></name><name><surname>Bou&#x000e2;ouda</surname><given-names>H</given-names></name><name><surname>Gourmelen</surname><given-names>S</given-names></name><name><surname>Dumont</surname><given-names>S</given-names></name><name><surname>Fuchs</surname><given-names>F</given-names></name><name><surname>Goumon</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Sleep deprivation and caffeine treatment potentiate photic resetting of the master circadian clock in a diurnal rodent</article-title><source>J Neurosci</source><year>2017</year><volume>37</volume><issue>16</issue><fpage>4343</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3241-16.2017</pub-id><pub-id pub-id-type="pmid">28320839</pub-id>
</element-citation><mixed-citation id="mc-CR86" publication-type="journal">Jha PK, Bou&#x000e2;ouda H, Gourmelen S, Dumont S, Fuchs F, Goumon Y, et al. Sleep deprivation and caffeine treatment potentiate photic resetting of the master circadian clock in a diurnal rodent. J Neurosci. 2017;37(16):4343&#x02013;58. 10.1523/JNEUROSCI.3241-16.2017.<pub-id pub-id-type="pmid">28320839</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name><surname>Reichert</surname><given-names>CF</given-names></name><name><surname>Veitz</surname><given-names>S</given-names></name><name><surname>B&#x000fc;hler</surname><given-names>M</given-names></name><name><surname>Gruber</surname><given-names>G</given-names></name><name><surname>Deuring</surname><given-names>G</given-names></name><name><surname>Rehm</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Wide awake at bedtime? Effects of caffeine on sleep and circadian timing in male adolescents&#x02013; A randomized crossover trial</article-title><source>Biochem Pharmacol</source><year>2021</year><volume>191</volume><fpage>114283</fpage><pub-id pub-id-type="doi">10.1016/j.bcp.2020.114283</pub-id><pub-id pub-id-type="pmid">33069664</pub-id>
</element-citation><mixed-citation id="mc-CR87" publication-type="journal">Reichert CF, Veitz S, B&#x000fc;hler M, Gruber G, Deuring G, Rehm SS, et al. Wide awake at bedtime? Effects of caffeine on sleep and circadian timing in male adolescents&#x02013; A randomized crossover trial. Biochem Pharmacol. 2021;191:114283. 10.1016/j.bcp.2020.114283.<pub-id pub-id-type="pmid">33069664</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Gong</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Does the timing of intake matter? Association between caffeine intake and depression: evidence from the National Health and Nutrition Examination Survey</article-title><source>J Affect Disord</source><year>2023</year><volume>340</volume><fpage>362</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jad.2023.07.115</pub-id><pub-id pub-id-type="pmid">37543113</pub-id>
</element-citation><mixed-citation id="mc-CR88" publication-type="journal">Yin J, Ding Y, Xu F, Zhao L, Gong R, Yang J, et al. Does the timing of intake matter? Association between caffeine intake and depression: evidence from the National Health and Nutrition Examination Survey. J Affect Disord. 2023;340:362&#x02013;8. 10.1016/j.jad.2023.07.115.<pub-id pub-id-type="pmid">37543113</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><collab>Health Quality Ontario</collab></person-group><article-title>Psychotherapy for major depressive disorder and generalized anxiety disorder: a Health Technology Assessment</article-title><source>Ont Health Technol Assess Ser</source><year>2017</year><volume>17</volume><issue>15</issue><fpage>1</fpage><lpage>167</lpage></element-citation><mixed-citation id="mc-CR89" publication-type="journal">Health Quality Ontario. Psychotherapy for major depressive disorder and generalized anxiety disorder: a Health Technology Assessment. Ont Health Technol Assess Ser. 2017;17(15):1&#x02013;167.</mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><mixed-citation publication-type="other">NIMH. Anxiety Disorders 2023 [cited 2024 02.01]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.nimh.nih.gov/health/topics/anxiety-disorders#part_2220">https://www.nimh.nih.gov/health/topics/anxiety-disorders#part_2220</ext-link></mixed-citation></ref><ref id="CR91"><label>91.</label><citation-alternatives><element-citation id="ec-CR91" publication-type="journal"><person-group person-group-type="author"><name><surname>Klevebrant</surname><given-names>L</given-names></name><name><surname>Frick</surname><given-names>A</given-names></name></person-group><article-title>Effects of caffeine on anxiety and panic attacks in patients with panic disorder: a systematic review and meta-analysis</article-title><source>Gen Hosp Psychiatry</source><year>2022</year><volume>74</volume><fpage>22</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.genhosppsych.2021.11.005</pub-id><pub-id pub-id-type="pmid">34871964</pub-id>
</element-citation><mixed-citation id="mc-CR91" publication-type="journal">Klevebrant L, Frick A. Effects of caffeine on anxiety and panic attacks in patients with panic disorder: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2022;74:22&#x02013;31. 10.1016/j.genhosppsych.2021.11.005.<pub-id pub-id-type="pmid">34871964</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR92"><label>92.</label><citation-alternatives><element-citation id="ec-CR92" publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>MR</given-names></name><name><surname>Williams</surname><given-names>PH</given-names></name><name><surname>McArthur</surname><given-names>JA</given-names></name><name><surname>Archuleta</surname><given-names>AR</given-names></name><name><surname>O&#x02019;Neill</surname><given-names>CE</given-names></name><name><surname>Hassell</surname><given-names>JE</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>Effects of chronic caffeine exposure during adolescence and subsequent acute caffeine challenge during adulthood on rat brain serotonergic systems</article-title><source>Neuropharmacology</source><year>2019</year><volume>148</volume><fpage>257</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2018.12.019</pub-id><pub-id pub-id-type="pmid">30579884</pub-id>
</element-citation><mixed-citation id="mc-CR92" publication-type="journal">Arnold MR, Williams PH, McArthur JA, Archuleta AR, O&#x02019;Neill CE, Hassell JE Jr., et al. Effects of chronic caffeine exposure during adolescence and subsequent acute caffeine challenge during adulthood on rat brain serotonergic systems. Neuropharmacology. 2019;148:257&#x02013;71. 10.1016/j.neuropharm.2018.12.019.<pub-id pub-id-type="pmid">30579884</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR93"><label>93.</label><citation-alternatives><element-citation id="ec-CR93" publication-type="journal"><person-group person-group-type="author"><name><surname>McLellan</surname><given-names>TM</given-names></name><name><surname>Caldwell</surname><given-names>JA</given-names></name><name><surname>Lieberman</surname><given-names>HR</given-names></name></person-group><article-title>A review of caffeine&#x02019;s effects on cognitive, physical and occupational performance</article-title><source>Neurosci Biobehavioral Reviews</source><year>2016</year><volume>71</volume><fpage>294</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.09.001</pub-id></element-citation><mixed-citation id="mc-CR93" publication-type="journal">McLellan TM, Caldwell JA, Lieberman HR. A review of caffeine&#x02019;s effects on cognitive, physical and occupational performance. Neurosci Biobehavioral Reviews. 2016;71:294&#x02013;312. 10.1016/j.neubiorev.2016.09.001.</mixed-citation></citation-alternatives></ref><ref id="CR94"><label>94.</label><citation-alternatives><element-citation id="ec-CR94" publication-type="journal"><person-group person-group-type="author"><name><surname>Trapp</surname><given-names>GS</given-names></name><name><surname>Allen</surname><given-names>K</given-names></name><name><surname>O&#x02019;Sullivan</surname><given-names>TA</given-names></name><name><surname>Robinson</surname><given-names>M</given-names></name><name><surname>Jacoby</surname><given-names>P</given-names></name><name><surname>Oddy</surname><given-names>WH</given-names></name></person-group><article-title>Energy drink consumption is associated with anxiety in Australian young adult males</article-title><source>Depress Anxiety</source><year>2014</year><volume>31</volume><issue>5</issue><fpage>420</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1002/da.22175</pub-id><pub-id pub-id-type="pmid">24019267</pub-id>
</element-citation><mixed-citation id="mc-CR94" publication-type="journal">Trapp GS, Allen K, O&#x02019;Sullivan TA, Robinson M, Jacoby P, Oddy WH. Energy drink consumption is associated with anxiety in Australian young adult males. Depress Anxiety. 2014;31(5):420&#x02013;8. 10.1002/da.22175.<pub-id pub-id-type="pmid">24019267</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR95"><label>95.</label><citation-alternatives><element-citation id="ec-CR95" publication-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>Z</given-names></name><name><surname>Cui</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The association between coffee consumption and risk of incident depression and anxiety: exploring the benefits of moderate intake</article-title><source>Psychiatry Res</source><year>2023</year><volume>326</volume><fpage>115307</fpage><pub-id pub-id-type="doi">10.1016/j.psychres.2023.115307</pub-id><pub-id pub-id-type="pmid">37352747</pub-id>
</element-citation><mixed-citation id="mc-CR95" publication-type="journal">Min J, Cao Z, Cui L, Li F, Lu Z, Hou Y, et al. The association between coffee consumption and risk of incident depression and anxiety: exploring the benefits of moderate intake. Psychiatry Res. 2023;326:115307. 10.1016/j.psychres.2023.115307.<pub-id pub-id-type="pmid">37352747</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR96"><label>96.</label><citation-alternatives><element-citation id="ec-CR96" publication-type="journal"><person-group person-group-type="author"><name><surname>Nouri-Majd</surname><given-names>S</given-names></name><name><surname>Salari-Moghaddam</surname><given-names>A</given-names></name><name><surname>Hassanzadeh Keshteli</surname><given-names>A</given-names></name><name><surname>Afshar</surname><given-names>H</given-names></name><name><surname>Esmaillzadeh</surname><given-names>A</given-names></name><name><surname>Adibi</surname><given-names>P</given-names></name></person-group><article-title>Coffee and caffeine intake in relation to symptoms of psychological disorders among adults</article-title><source>Public Health Nutr</source><year>2022</year><volume>25</volume><issue>12</issue><fpage>1</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1017/S1368980022000271</pub-id><pub-id pub-id-type="pmid">35094730</pub-id>
</element-citation><mixed-citation id="mc-CR96" publication-type="journal">Nouri-Majd S, Salari-Moghaddam A, Hassanzadeh Keshteli A, Afshar H, Esmaillzadeh A, Adibi P. Coffee and caffeine intake in relation to symptoms of psychological disorders among adults. Public Health Nutr. 2022;25(12):1&#x02013;28. 10.1017/S1368980022000271.<pub-id pub-id-type="pmid">35094730</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR97"><label>97.</label><mixed-citation publication-type="other">Jahrami H, Al-Mutarid M, Penson PE, Al-Islam Faris M, Saif Z, Hammad L. Intake of Caffeine and Its Association with Physical and Mental Health Status among University students in Bahrain. Foods. 2020;9(4). 10.3390/foods9040473.</mixed-citation></ref><ref id="CR98"><label>98.</label><citation-alternatives><element-citation id="ec-CR98" publication-type="journal"><person-group person-group-type="author"><name><surname>Kasimay Cakir</surname><given-names>O</given-names></name><name><surname>Ellek</surname><given-names>N</given-names></name><name><surname>Salehin</surname><given-names>N</given-names></name><name><surname>Hamamc&#x00131;</surname><given-names>R</given-names></name><name><surname>Kele&#x0015f;</surname><given-names>H</given-names></name><name><surname>Kayal&#x00131;</surname><given-names>DG</given-names></name><etal/></person-group><article-title>Protective effect of low dose caffeine on psychological stress and cognitive function</article-title><source>Physiol Behav</source><year>2017</year><volume>168</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.physbeh.2016.10.010</pub-id><pub-id pub-id-type="pmid">27746260</pub-id>
</element-citation><mixed-citation id="mc-CR98" publication-type="journal">Kasimay Cakir O, Ellek N, Salehin N, Hamamc&#x00131; R, Kele&#x0015f; H, Kayal&#x00131; DG, et al. Protective effect of low dose caffeine on psychological stress and cognitive function. Physiol Behav. 2017;168:1&#x02013;10. 10.1016/j.physbeh.2016.10.010.<pub-id pub-id-type="pmid">27746260</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR99"><label>99.</label><citation-alternatives><element-citation id="ec-CR99" publication-type="journal"><person-group person-group-type="author"><name><surname>Flor&#x000e9;n Lind</surname><given-names>F</given-names></name><name><surname>Stam</surname><given-names>S</given-names></name><name><surname>Zelleroth</surname><given-names>S</given-names></name><name><surname>Meurling</surname><given-names>E</given-names></name><name><surname>Frick</surname><given-names>A</given-names></name><name><surname>Gr&#x000f6;nbladh</surname><given-names>A</given-names></name></person-group><article-title>Acute caffeine differently affects risk-taking and the expression of BDNF and of adenosine and opioid receptors in rats with high or low anxiety-like behavior</article-title><source>Pharmacol Biochem Behav</source><year>2023</year><volume>227&#x02013;228</volume><fpage>173573</fpage><pub-id pub-id-type="doi">10.1016/j.pbb.2023.173573</pub-id><pub-id pub-id-type="pmid">37302662</pub-id>
</element-citation><mixed-citation id="mc-CR99" publication-type="journal">Flor&#x000e9;n Lind F, Stam S, Zelleroth S, Meurling E, Frick A, Gr&#x000f6;nbladh A. Acute caffeine differently affects risk-taking and the expression of BDNF and of adenosine and opioid receptors in rats with high or low anxiety-like behavior. Pharmacol Biochem Behav. 2023;227&#x02013;228:173573. <ext-link ext-link-type="uri" xlink:href="https://www.sciencedirect.com/science/article/pii/S0091305723000606">https://www.sciencedirect.com/science/article/pii/S0091305723000606</ext-link>.<pub-id pub-id-type="pmid">37302662</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR100"><label>100.</label><citation-alternatives><element-citation id="ec-CR100" publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>DG</given-names></name><name><surname>Lara</surname><given-names>MVS</given-names></name><name><surname>Dobler</surname><given-names>PB</given-names></name><name><surname>Almeida</surname><given-names>RF</given-names></name><name><surname>Porci&#x000fa;ncula</surname><given-names>LO</given-names></name></person-group><article-title>Caffeine prevents neurodegeneration and behavioral alterations in a mice model of agitated depression</article-title><source>Prog Neuropsychopharmacol Biol Psychiatry</source><year>2020</year><volume>98</volume><fpage>109776</fpage><pub-id pub-id-type="doi">10.1016/j.pnpbp.2019.109776</pub-id><pub-id pub-id-type="pmid">31707092</pub-id>
</element-citation><mixed-citation id="mc-CR100" publication-type="journal">Machado DG, Lara MVS, Dobler PB, Almeida RF, Porci&#x000fa;ncula LO. Caffeine prevents neurodegeneration and behavioral alterations in a mice model of agitated depression. Prog Neuropsychopharmacol Biol Psychiatry. 2020;98:109776. <ext-link ext-link-type="uri" xlink:href="https://www.sciencedirect.com/science/article/pii/S0278584619304828">https://www.sciencedirect.com/science/article/pii/S0278584619304828</ext-link>.<pub-id pub-id-type="pmid">31707092</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR101"><label>101.</label><citation-alternatives><element-citation id="ec-CR101" publication-type="journal"><person-group person-group-type="author"><name><surname>File</surname><given-names>SE</given-names></name><name><surname>Baldwin</surname><given-names>HA</given-names></name><name><surname>Johnston</surname><given-names>AL</given-names></name><name><surname>Wilks</surname><given-names>LJ</given-names></name></person-group><article-title>Behavioral effects of acute and chronic administration of caffeine in the rat</article-title><source>Pharmacol Biochem Behav</source><year>1988</year><volume>30</volume><issue>4</issue><fpage>809</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/0091-3057(88)90104-9</pub-id><pub-id pub-id-type="pmid">3227034</pub-id>
</element-citation><mixed-citation id="mc-CR101" publication-type="journal">File SE, Baldwin HA, Johnston AL, Wilks LJ. Behavioral effects of acute and chronic administration of caffeine in the rat. Pharmacol Biochem Behav. 1988;30(4):809&#x02013;15. <ext-link ext-link-type="uri" xlink:href="https://www.sciencedirect.com/science/article/pii/0091305788901049">https://www.sciencedirect.com/science/article/pii/0091305788901049</ext-link>.<pub-id pub-id-type="pmid">3227034</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR102"><label>102.</label><citation-alternatives><element-citation id="ec-CR102" publication-type="journal"><person-group person-group-type="author"><name><surname>Booth</surname><given-names>N</given-names></name><name><surname>Saxton</surname><given-names>J</given-names></name><name><surname>Rodda</surname><given-names>SN</given-names></name></person-group><article-title>Estimates of Caffeine Use Disorder, Caffeine Withdrawal, Harm and help-seeking in New Zealand: a cross-sectional survey</article-title><source>Addict Behav</source><year>2020</year><volume>109</volume><fpage>106470</fpage><pub-id pub-id-type="doi">10.1016/j.addbeh.2020.106470</pub-id><pub-id pub-id-type="pmid">32485545</pub-id>
</element-citation><mixed-citation id="mc-CR102" publication-type="journal">Booth N, Saxton J, Rodda SN. Estimates of Caffeine Use Disorder, Caffeine Withdrawal, Harm and help-seeking in New Zealand: a cross-sectional survey. Addict Behav. 2020;109:106470. 10.1016/j.addbeh.2020.106470.<pub-id pub-id-type="pmid">32485545</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR103"><label>103.</label><citation-alternatives><element-citation id="ec-CR103" publication-type="journal"><person-group person-group-type="author"><name><surname>Turnbull</surname><given-names>D</given-names></name><name><surname>Rodricks</surname><given-names>JV</given-names></name><name><surname>Mariano</surname><given-names>GF</given-names></name></person-group><article-title>Neurobehavioral hazard identification and characterization for caffeine</article-title><source>Regul Toxicol Pharmacol</source><year>2016</year><volume>74</volume><fpage>81</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.yrtph.2015.12.002</pub-id><pub-id pub-id-type="pmid">26702789</pub-id>
</element-citation><mixed-citation id="mc-CR103" publication-type="journal">Turnbull D, Rodricks JV, Mariano GF. Neurobehavioral hazard identification and characterization for caffeine. Regul Toxicol Pharmacol. 2016;74:81&#x02013;92. 10.1016/j.yrtph.2015.12.002.<pub-id pub-id-type="pmid">26702789</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR104"><label>104.</label><citation-alternatives><element-citation id="ec-CR104" publication-type="journal"><person-group person-group-type="author"><name><surname>Kapellou</surname><given-names>A</given-names></name><name><surname>King</surname><given-names>A</given-names></name><name><surname>Graham</surname><given-names>CAM</given-names></name><name><surname>Pilic</surname><given-names>L</given-names></name><name><surname>Mavrommatis</surname><given-names>Y</given-names></name></person-group><article-title>Genetics of caffeine and brain-related outcomes&#x02013; a systematic review of observational studies and randomized trials</article-title><source>Nutr Rev</source><year>2023</year><volume>81</volume><issue>12</issue><fpage>1571</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1093/nutrit/nuad029</pub-id><pub-id pub-id-type="pmid">37029915</pub-id>
</element-citation><mixed-citation id="mc-CR104" publication-type="journal">Kapellou A, King A, Graham CAM, Pilic L, Mavrommatis Y. Genetics of caffeine and brain-related outcomes&#x02013; a systematic review of observational studies and randomized trials. Nutr Rev. 2023;81(12):1571&#x02013;98. 10.1093/nutrit/nuad029.<pub-id pub-id-type="pmid">37029915</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR105"><label>105.</label><mixed-citation publication-type="other">Fulton JL, Dinas PC, Carrillo AE, Edsall JR, Ryan EJ, Ryan EJ. Impact of genetic variability on physiological responses to Caffeine in humans: a systematic review. Nutrients. 2018;10(10). 10.3390/nu10101373.</mixed-citation></ref><ref id="CR106"><label>106.</label><mixed-citation publication-type="other">WHO. Stress 2023 [cited 2024 04.03]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/questions-and-answers/item/stress/">https://www.who.int/news-room/questions-and-answers/item/stress/</ext-link></mixed-citation></ref><ref id="CR107"><label>107.</label><mixed-citation publication-type="other">Tsigos C, Kyrou I, Kassi E, Chrousos GP, Stress. Endocrine physiology and pathophysiology. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al. editors. Endotext. South Dartmouth (MA). MDText.com, Inc.; 2000.</mixed-citation></ref><ref id="CR108"><label>108.</label><citation-alternatives><element-citation id="ec-CR108" publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>KA</given-names></name><name><surname>Stromin</surname><given-names>JI</given-names></name><name><surname>Steenkamp</surname><given-names>N</given-names></name><name><surname>Combrinck</surname><given-names>MI</given-names></name></person-group><article-title>Understanding the relationships between physiological and psychosocial stress, cortisol and cognition</article-title><source>Front Endocrinol (Lausanne)</source><year>2023</year><volume>14</volume><fpage>1085950</fpage><pub-id pub-id-type="doi">10.3389/fendo.2023.1085950</pub-id><pub-id pub-id-type="pmid">36950689</pub-id>
</element-citation><mixed-citation id="mc-CR108" publication-type="journal">James KA, Stromin JI, Steenkamp N, Combrinck MI. Understanding the relationships between physiological and psychosocial stress, cortisol and cognition. Front Endocrinol (Lausanne). 2023;14:1085950. 10.3389/fendo.2023.1085950.<pub-id pub-id-type="pmid">36950689</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR109"><label>109.</label><mixed-citation publication-type="other">Chu B, Marwaha K, Sanvictores T, Awosika AO, Ayers D, Physiology. Stress reaction. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.</mixed-citation></ref><ref id="CR110"><label>110.</label><citation-alternatives><element-citation id="ec-CR110" publication-type="journal"><person-group person-group-type="author"><name><surname>Kaster</surname><given-names>MP</given-names></name><name><surname>Machado</surname><given-names>NJ</given-names></name><name><surname>Silva</surname><given-names>HB</given-names></name><name><surname>Nunes</surname><given-names>A</given-names></name><name><surname>Ardais</surname><given-names>AP</given-names></name><name><surname>Santana</surname><given-names>M</given-names></name><etal/></person-group><article-title>Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress</article-title><source>Proc Natl Acad Sci U S A</source><year>2015</year><volume>112</volume><issue>25</issue><fpage>7833</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1073/pnas.1423088112</pub-id><pub-id pub-id-type="pmid">26056314</pub-id>
</element-citation><mixed-citation id="mc-CR110" publication-type="journal">Kaster MP, Machado NJ, Silva HB, Nunes A, Ardais AP, Santana M, et al. Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress. Proc Natl Acad Sci U S A. 2015;112(25):7833&#x02013;8. 10.1073/pnas.1423088112.<pub-id pub-id-type="pmid">26056314</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR111"><label>111.</label><citation-alternatives><element-citation id="ec-CR111" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>da Silva</surname><given-names>BS</given-names></name><name><surname>Zheng</surname><given-names>W</given-names></name><name><surname>Xiang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Lateral septum adenosine A(2A) receptors control stress-induced depressive-like behaviors via signaling to the hypothalamus and habenula</article-title><source>Nat Commun</source><year>2023</year><volume>14</volume><issue>1</issue><fpage>1880</fpage><pub-id pub-id-type="doi">10.1038/s41467-023-37601-x</pub-id><pub-id pub-id-type="pmid">37019936</pub-id>
</element-citation><mixed-citation id="mc-CR111" publication-type="journal">Wang M, Li P, Li Z, da Silva BS, Zheng W, Xiang Z, et al. Lateral septum adenosine A(2A) receptors control stress-induced depressive-like behaviors via signaling to the hypothalamus and habenula. Nat Commun. 2023;14(1):1880.<pub-id pub-id-type="pmid">37019936</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR112"><label>112.</label><citation-alternatives><element-citation id="ec-CR112" publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>MK</given-names></name><name><surname>Kamal</surname><given-names>M</given-names></name><name><surname>Tikamdas</surname><given-names>R</given-names></name><name><surname>Nouh</surname><given-names>RA</given-names></name><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Sayed</surname><given-names>M</given-names></name></person-group><article-title>Effects of Chronic Caffeine Administration on behavioral and molecular adaptations to sensory contact Model Induced stress in adolescent male mice</article-title><source>Behav Genet</source><year>2020</year><volume>50</volume><issue>5</issue><fpage>374</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1007/s10519-020-10003-1</pub-id><pub-id pub-id-type="pmid">32504257</pub-id>
</element-citation><mixed-citation id="mc-CR112" publication-type="journal">Ibrahim MK, Kamal M, Tikamdas R, Nouh RA, Tian J, Sayed M. Effects of Chronic Caffeine Administration on behavioral and molecular adaptations to sensory contact Model Induced stress in adolescent male mice. Behav Genet. 2020;50(5):374&#x02013;83. 10.1007/s10519-020-10003-1.<pub-id pub-id-type="pmid">32504257</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR113"><label>113.</label><citation-alternatives><element-citation id="ec-CR113" publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>NJ</given-names></name><name><surname>Ardais</surname><given-names>AP</given-names></name><name><surname>Nunes</surname><given-names>A</given-names></name><name><surname>Szab&#x000f3;</surname><given-names>EC</given-names></name><name><surname>Silveirinha</surname><given-names>V</given-names></name><name><surname>Silva</surname><given-names>HB</given-names></name><etal/></person-group><article-title>Impact of Coffee Intake on measures of Wellbeing in mice</article-title><source>Nutrients</source><year>2024</year><volume>16</volume><issue>17</issue><fpage>2920</fpage><pub-id pub-id-type="doi">10.3390/nu16172920</pub-id><pub-id pub-id-type="pmid">39275237</pub-id>
</element-citation><mixed-citation id="mc-CR113" publication-type="journal">Machado NJ, Ardais AP, Nunes A, Szab&#x000f3; EC, Silveirinha V, Silva HB, et al. Impact of Coffee Intake on measures of Wellbeing in mice. Nutrients. 2024;16(17):2920. <ext-link ext-link-type="uri" xlink:href="https://www.mdpi.com/2072-6643/16/17/2920">https://www.mdpi.com/2072-6643/16/17/2920</ext-link>.<pub-id pub-id-type="pmid">39275237</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR114"><label>114.</label><citation-alternatives><element-citation id="ec-CR114" publication-type="journal"><person-group person-group-type="author"><name><surname>Devi</surname><given-names>SSL</given-names></name><name><surname>Abilash</surname><given-names>S</given-names></name><name><surname>Basalingappa</surname><given-names>S</given-names></name></person-group><article-title>The rationale of caffeine consumption and its symptoms during preparatory and non-preparatory days: a study among medical students</article-title><source>Biomed Pharmacol J</source><year>2018</year><volume>11</volume><issue>2</issue><fpage>1153</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.13005/bpj/1476</pub-id></element-citation><mixed-citation id="mc-CR114" publication-type="journal">Devi SSL, Abilash S, Basalingappa S. The rationale of caffeine consumption and its symptoms during preparatory and non-preparatory days: a study among medical students. Biomed Pharmacol J. 2018;11(2):1153&#x02013;9. 10.13005/bpj/1476.</mixed-citation></citation-alternatives></ref><ref id="CR115"><label>115.</label><citation-alternatives><element-citation id="ec-CR115" publication-type="journal"><person-group person-group-type="author"><name><surname>Aboelnaga</surname><given-names>SMH</given-names></name></person-group><article-title>Caffeine and its impact with physical and Status of Mental Health among University students in the United Kingdom</article-title><source>J Pharm Res Int</source><year>2021</year><volume>33</volume><issue>1</issue><fpage>32</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.9734/jpri/2021/v33i131135</pub-id></element-citation><mixed-citation id="mc-CR115" publication-type="journal">Aboelnaga SMH. Caffeine and its impact with physical and Status of Mental Health among University students in the United Kingdom. J Pharm Res Int. 2021;33(1):32&#x02013;8. 10.9734/jpri/2021/v33i131135.</mixed-citation></citation-alternatives></ref><ref id="CR116"><label>116.</label><citation-alternatives><element-citation id="ec-CR116" publication-type="journal"><person-group person-group-type="author"><name><surname>Makki</surname><given-names>NM</given-names></name><name><surname>Alharbi</surname><given-names>ST</given-names></name><name><surname>Alharbi</surname><given-names>AM</given-names></name><name><surname>Alsharif</surname><given-names>AS</given-names></name><name><surname>Aljabri</surname><given-names>AM</given-names></name></person-group><article-title>Caffeine consumption and depression, anxiety, and stress levels among University students in Medina: a cross-sectional study</article-title><source>Cureus</source><year>2023</year><volume>15</volume><issue>10</issue><fpage>e48018</fpage><pub-id pub-id-type="doi">10.7759/cureus.48018</pub-id><pub-id pub-id-type="pmid">37916247</pub-id>
</element-citation><mixed-citation id="mc-CR116" publication-type="journal">Makki NM, Alharbi ST, Alharbi AM, Alsharif AS, Aljabri AM. Caffeine consumption and depression, anxiety, and stress levels among University students in Medina: a cross-sectional study. Cureus. 2023;15(10):e48018. 10.7759/cureus.48018.<pub-id pub-id-type="pmid">37916247</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR117"><label>117.</label><citation-alternatives><element-citation id="ec-CR117" publication-type="journal"><person-group person-group-type="author"><name><surname>Akova</surname><given-names>&#x00130;</given-names></name><name><surname>Duman</surname><given-names>E</given-names></name><name><surname>Sahar</surname><given-names>A</given-names></name><name><surname>S&#x000fc;mer</surname><given-names>E</given-names></name></person-group><article-title>The relationship between caffeine consumption and depression, anxiety, stress level and Sleep Quality in Medical Students</article-title><source>J Turkish Sleep Med</source><year>2023</year><volume>10</volume><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.4274/jtsm.galenos.2022.06078</pub-id></element-citation><mixed-citation id="mc-CR117" publication-type="journal">Akova &#x00130;, Duman E, Sahar A, S&#x000fc;mer E. The relationship between caffeine consumption and depression, anxiety, stress level and Sleep Quality in Medical Students. J Turkish Sleep Med. 2023;10:65&#x02013;70.</mixed-citation></citation-alternatives></ref><ref id="CR118"><label>118.</label><mixed-citation publication-type="other">FDA. How Much Caffeine is Too Much? n.d. [cited 2024 01.01]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/consumers/consumer-updates/spilling-beans-how-much-caffeine-too-much">https://www.fda.gov/consumers/consumer-updates/spilling-beans-how-much-caffeine-too-much</ext-link></mixed-citation></ref><ref id="CR119"><label>119.</label><mixed-citation publication-type="other">Health Canada. Caffeine in Foods 2022 [Available from: <ext-link ext-link-type="uri" xlink:href="https://www.canada.ca/en/health-canada/services/food-nutrition/food-safety/food-additives/caffeine-foods.html#a2">https://www.canada.ca/en/health-canada/services/food-nutrition/food-safety/food-additives/caffeine-foods.html#a2</ext-link></mixed-citation></ref><ref id="CR120"><label>120.</label><citation-alternatives><element-citation id="ec-CR120" publication-type="journal"><person-group person-group-type="author"><name><surname>Benowitz</surname><given-names>NL</given-names></name></person-group><article-title>Clinical pharmacology of caffeine</article-title><source>Annu Rev Med</source><year>1990</year><volume>41</volume><fpage>277</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1146/annurev.me.41.020190.001425</pub-id><pub-id pub-id-type="pmid">2184730</pub-id>
</element-citation><mixed-citation id="mc-CR120" publication-type="journal">Benowitz NL. Clinical pharmacology of caffeine. Annu Rev Med. 1990;41:277&#x02013;88. 10.1146/annurev.me.41.020190.001425.<pub-id pub-id-type="pmid">2184730</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR121"><label>121.</label><citation-alternatives><element-citation id="ec-CR121" publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>P</given-names></name><name><surname>Ali</surname><given-names>Z</given-names></name><name><surname>Levine</surname><given-names>B</given-names></name><name><surname>Fowler</surname><given-names>DR</given-names></name></person-group><article-title>Fatal caffeine intoxication: a series of eight cases from 1999 to 2009</article-title><source>J Forensic Sci</source><year>2014</year><volume>59</volume><issue>3</issue><fpage>865</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1111/1556-4029.12387</pub-id><pub-id pub-id-type="pmid">24502704</pub-id>
</element-citation><mixed-citation id="mc-CR121" publication-type="journal">Banerjee P, Ali Z, Levine B, Fowler DR. Fatal caffeine intoxication: a series of eight cases from 1999 to 2009. J Forensic Sci. 2014;59(3):865&#x02013;8. 10.1111/1556-4029.12387.<pub-id pub-id-type="pmid">24502704</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR122"><label>122.</label><citation-alternatives><element-citation id="ec-CR122" publication-type="journal"><person-group person-group-type="author"><name><surname>Van Dam</surname><given-names>RM</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name></person-group><article-title>Coffee, Caffeine, and Health</article-title><source>N Engl J Med</source><year>2020</year><volume>383</volume><issue>4</issue><fpage>369</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1816604</pub-id><pub-id pub-id-type="pmid">32706535</pub-id>
</element-citation><mixed-citation id="mc-CR122" publication-type="journal">Van Dam RM, Hu FB, Willett WC. Coffee, Caffeine, and Health. N Engl J Med. 2020;383(4):369&#x02013;78. 10.1056/NEJMra1816604.<pub-id pub-id-type="pmid">32706535</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR123"><label>123.</label><citation-alternatives><element-citation id="ec-CR123" publication-type="journal"><person-group person-group-type="author"><name><surname>Guest</surname><given-names>NS</given-names></name><name><surname>Horne</surname><given-names>J</given-names></name><name><surname>Vanderhout</surname><given-names>SM</given-names></name><name><surname>El-Sohemy</surname><given-names>A</given-names></name></person-group><article-title>Sport Nutrigenomics: Personalized Nutrition for athletic performance</article-title><source>Front Nutr</source><year>2019</year><volume>6</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.3389/fnut.2019.00008</pub-id><pub-id pub-id-type="pmid">30838211</pub-id>
</element-citation><mixed-citation id="mc-CR123" publication-type="journal">Guest NS, Horne J, Vanderhout SM, El-Sohemy A. Sport Nutrigenomics: Personalized Nutrition for athletic performance. Front Nutr. 2019;6:8. 10.3389/fnut.2019.00008.<pub-id pub-id-type="pmid">30838211</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>